Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014218	ab-hco3-st	mmol/l (mmol/l)	21949	254336	0.00%
3014218	ab-standardibikarbonaatti	mmol/l (mmol/l)	1973	4195	0.00%
3014218	ab-hco3-st	— (—)	1313	2880	100.00%	Distribution not available
3014218	ab-hco3-st	mmol/l____ (mmol/l)	698	1494	0.00%
3014218	bikarbonaatti(aktuaali),valtimoveri	mmol/l (mmol/l)	427	800	0.00%
3014218	ab-bikarbonaatti	mmol/l (mmol/l)	350	557	0.00%
3014218	ap-hco3st	mmol/l____ (mmol/l)	257	616	0.00%
3014218	ab-standardibikarbonaatti	mmol/l____ (mmol/l)	157	235	0.00%
3014218	ap-shco3	mmol/l (mmol/l)	141	192	0.00%
3014218	ap-hco3st	mmol/l (mmol/l)	82	134	0.00%
3014218	bikarbonaatti(aktuaali),valtimoveri	mmol/l____ (mmol/l)	33	38	0.00%
3014218	ap-shco3	— (—)	33	39	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Haemorrhage from respiratory passages

2196

8146

2.56

320.45

10.9

9.8

24.32

24.11

mmol/l

2.14

2130

7993

Colorectal cancer, including Hilmo

1854

6780

2.79

318.16

8.8

9.4

23.85

24.39

mmol/l

11.60

1834

6564

Parasetamol

3331

7908

2.21

317.30

10.8

10.5

24.15

24.13

mmol/l

0.12

3253

7722

Symptoms and signs involving the circulatory and respiratory systems

4672

12477

1.94

316.29

10.3

10.5

24.29

24.09

mmol/l

3.71

4547

12249

Insulin medication

3524

14843

2.08

313.67

13.2

9.1

23.81

24.37

mmol/l

14.83

3414

14499

ILD medications: immunosuppressive drugs

3351

15227

2.09

310.77

15.2

10.0

24.04

24.18

mmol/l

1.71

3285

14952

Ischaemic heart disease, wide definition

4294

14114

1.97

310.04

12.5

9.4

24.19

24.38

mmol/l

2.96

4196

13849

Antihypertensive medication - note that there are other indications

2318

4902

2.56

308.99

13.5

8.7

24.06

24.29

mmol/l

2.51

2278

4810

Endocrine, nutritional and metabolic diseases

3477

8475

2.14

308.72

12.8

8.7

24.09

24.33

mmol/l

3.73

3406

8302

Other respiratory disorders and diseases

1944

5769

3.94

307.65

12.6

8.7

25.92

24.08

mmol/l

75.90

1886

5595

STROKE

3358

8350

2.91

307.65

12.5

8.1

24.31

24.47

mmol/l

1.99

3299

8198

Asthma-related pneumonia or sepsis

2861

10336

3.05

307.65

10.8

9.0

24.93

24.14

mmol/l

25.53

2764

10058

General symptoms and signs

5677

13582

2.19

307.65

10.6

9.9

24.29

24.18

mmol/l

1.66

5561

13299

Hypertensive diseases

4091

9831

2.47

307.65

13.1

9.5

24.11

24.39

mmol/l

5.64

4019

9629

Renal failure

4339

12744

3.28

307.65

15.6

8.3

23.03

24.53

mmol/l

105.66

4203

12407

Hypothyroidism and >3 levothyroxin purchases

819

770

6.22

307.65

12.7

6.3

24.10

24.20

mmol/l

0.30

804

757

Continuous positive airway pressure

1536

2377

6.18

307.65

11.9

7.2

24.77

24.15

mmol/l

7.66

1487

2342

Abnormalities of breathing

5214

12456

2.53

307.65

10.0

10.5

24.58

24.09

mmol/l

19.29

5061

12228

Asthma-related infections

3699

16169

2.37

307.65

10.3

9.7

24.83

24.13

mmol/l

28.89

3586

15784

Anaemias

1342

750

12.58

307.65

15.3

6.3

23.69

24.18

mmol/l

3.21

1320

737

Other chronic obstructive pulmonary disease

3758

10665

3.25

307.65

9.5

25.10

24.03

mmol/l

58.71

3625

10443

Condition for Implicit Sepsis (Organ dysfunction codes)

6299

15347

3.09

307.65

14.4

8.4

24.13

24.33

mmol/l

3.41

6153

15018

Bacterial Sepsis

4433

11012

3.79

307.65

14.7

7.9

24.18

24.28

mmol/l

0.90

4287

10750

Certain infectious and parasitic diseases

4845

12079

2.09

307.65

11.6

8.9

24.25

24.24

mmol/l

0.09

4724

11858

Abnormal findings on diagnostic imaging of lung

3224

14642

2.24

307.65

10.0

9.2

24.79

24.18

mmol/l

21.25

3147

14282

Other CVD (FINNGEN)

798

1131

6.08

307.65

11.0

7.3

24.49

24.26

mmol/l

0.86

774

1116

Ischemic heart diseases

4783

13614

2.21

307.65

15.0

8.8

24.21

24.37

mmol/l

2.42

4691

13356

Cerebrovascular diseases (FINNGEN)

2329

2933

6.26

307.65

13.6

7.5

24.30

24.32

mmol/l

0.13

2302

2883

Erysipelas

3710

13665

2.51

307.65

10.6

8.8

24.40

24.30

mmol/l

0.98

3596

13367

Metabolic disorders

5923

14916

2.53

307.65

11.9

9.3

24.14

24.33

mmol/l

3.92

5787

14570

Myocardial infarction

3047

9880

2.31

307.65

12.2

8.5

23.96

24.35

mmol/l

7.83

2961

9680

Septicaemia

3497

10776

3.30

307.65

14.8

8.4

23.83

24.29

mmol/l

10.12

3402

10526

Malignant neoplasm, including Hilmo

4969

12793

2.39

307.65

10.1

10.9

24.22

24.34

mmol/l

1.71

4907

12437

Non-rheumatic valve diseases

2953

8132

2.79

307.65

12.7

8.5

24.22

24.21

mmol/l

0.06

2890

7981

Explicit Sepsis, including avohilmo

3664

10928

3.38

307.65

14.8

8.0

23.86

24.27

mmol/l

8.60

3566

10666

Malignant neoplasm of digestive organs, including Hilmo

3000

8824

2.72

307.65

10.6

10.0

23.98

24.39

mmol/l

9.86

2970

8551

Diabetes mellitus

5114

16248

1.88

307.65

13.1

8.9

23.99

24.40

mmol/l

12.92

4990

15882

First line medication for Crohn's disease

6231

15783

2.23

307.65

10.9

10.0

24.34

24.12

mmol/l

5.25

6079

15427

Viral Sepsis

1723

5152

3.79

307.65

14.1

8.0

24.31

mmol/l

0.00

1667

5018

Implicit viral Sepsis, including avohilmo

2418

7731

3.49

307.65

13.3

7.9

24.32

24.30

mmol/l

0.09

2347

7537

Asthma, hospital admissions 3, pneumonia

2861

10336

3.05

307.65

10.8

9.0

24.93

24.14

mmol/l

25.53

2764

10058

Any event in cancer register

5189

13244

2.41

307.65

9.8

10.9

24.20

24.33

mmol/l

2.09

5127

12875

Dyspnoea

6171

18465

2.58

307.65

9.7

10.0

24.61

24.13

mmol/l

21.93

5997

18055

Excluding asthma or asthma-COPD overlap

3739

8554

2.28

307.65

11.5

9.0

24.48

23.81

mmol/l

27.35

3663

8441

Heart failure, not strict

6332

12854

3.72

307.65

14.5

8.8

24.30

24.23

mmol/l

0.80

6189

12636

Heart failure,strict

4668

9744

3.81

307.65

13.2

8.7

24.47

24.21

mmol/l

4.35

4541

9565

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6305

17006

2.06

307.65

11.3

9.5

24.18

24.24

mmol/l

0.78

6205

16567

Asthma, hospital admission 2, infections

3699

16169

2.37

307.65

10.3

9.7

24.83

24.13

mmol/l

28.89

3586

15784

Persons encountering health services in other circumstances, wide

6278

17109

1.96

307.65

10.9

9.5

24.23

24.24

mmol/l

0.10

6161

16650

Hypertensive Heart Disease

1663

4394

3.15

307.65

9.8

8.2

24.20

24.41

mmol/l

1.43

1617

4283

Bleeding

5389

17672

2.28

307.65

12.1

9.4

24.21

24.29

mmol/l

0.85

5263

17257

COPD, hospital admissions

3751

11874

2.98

307.65

9.4

9.3

25.10

24.06

mmol/l

57.38

3619

11610

Any reimbursement code in KELA

2331

4035

3.01

307.65

12.4

8.8

24.25

24.22

mmol/l

0.17

2295

3955

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5359

17600

2.01

307.65

14.3

9.0

24.05

24.29

mmol/l

6.06

5257

17198

Asthma

4166

8476

2.67

307.65

9.7

9.0

24.66

23.81

mmol/l

44.68

4056

8364

Examination and observation for other reasons

3642

8654

2.52

307.65

11.0

10.3

24.26

24.29

mmol/l

0.21

3571

8467

Persons encountering health services for specific procedures, not carried out

817

1675

5.83

307.65

12.3

9.6

23.98

24.30

mmol/l

1.81

791

1649

Solid cancers

4742

12500

2.35

307.65

9.7

10.8

24.25

24.35

mmol/l

1.45

4683

12153

3657

15717

2.14

307.65

13.2

9.9

24.14

24.17

mmol/l

0.19

3553

15383

Adjustment and management of implanted device

1496

5113

3.32

307.65

15.1

8.4

24.17

24.23

mmol/l

0.32

1469

4956

Neoplasms

3454

8376

2.24

307.65

10.7

11.9

24.14

24.20

mmol/l

0.54

3403

8148

Other medical care

3086

11804

2.34

307.65

8.5

8.9

24.50

24.26

mmol/l

3.42

3033

11500

Asthma (only as main-diagnosis)

3728

8476

2.58

307.65

8.8

9.0

24.67

23.81

mmol/l

42.28

3636

8364

Early onset COPD

1737

5928

3.32

307.65

11.3

10.4

25.24

24.07

mmol/l

34.66

1688

5823

COPD-related respiratory insufficiency

1334

3159

5.32

307.65

11.4

8.9

25.74

24.01

mmol/l

45.84

1280

3075

Complications of medical and surgical care

4584

19441

2.25

307.65

12.1

9.2

24.24

24.28

mmol/l

0.42

4497

18957

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1883

3653

3.42

307.65

12.1

7.4

24.20

24.28

mmol/l

0.46

1856

3588

ILD differential diagnosis

3715

8564

2.26

307.65

11.4

9.1

24.49

23.81

mmol/l

28.50

3639

8452

Implicit Sepsis, including avohilmo

6326

15435

3.20

307.65

14.3

8.4

24.15

24.31

mmol/l

2.54

6167

15102

Cardiovascular diseases (excluding rheumatic etc)

3070

4717

3.94

307.65

14.2

7.9

24.14

24.15

mmol/l

0.05

3023

4626

Persons encountering health services for specific procedures and health care

6665

16805

2.48

307.65

12.1

9.6

24.21

24.24

mmol/l

0.32

6525

16393

Care involving dialysis

864

1829

5.99

307.65

17.9

10.2

22.62

24.28

mmol/l

32.10

838

1799

Cerebrovascular diseases

4873

16048

2.25

307.65

10.9

9.5

24.26

24.29

mmol/l

0.27

4767

15673

COPD related to multimorbidity

3355

10425

3.06

307.65

9.5

9.1

25.04

24.04

mmol/l

44.76

3229

10187

COPD/asthma related infections

5151

12763

2.11

307.65

11.1

8.9

24.57

23.99

mmol/l

25.88

5031

12561

Implicit bacterial Sepsis

3981

10115

3.86

307.65

15.0

7.8

24.18

24.29

mmol/l

0.91

3846

9860

Malignant neoplasm

4788

12654

2.34

307.65

10.0

10.8

24.24

24.34

mmol/l

1.30

4729

12304

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3728

17677

2.19

307.65

12.1

9.0

24.23

24.29

mmol/l

0.56

3665

17241

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4235

18104

2.16

307.65

10.1

9.5

24.67

24.20

mmol/l

16.95

4136

17672

Respiratory insufficiency

1122

1562

9.63

307.65

11.8

8.5

26.54

23.69

mmol/l

87.25

1087

1541

Hypertensive heart and/or renal disease

1850

4619

3.22

307.65

9.9

8.4

24.10

24.41

mmol/l

2.88

1795

4505

COPD (mode)

2989

5516

4.93

307.65

9.7

8.8

25.15

23.80

mmol/l

65.17

2896

5443

COPD differential diagnosis

3720

8564

2.26

307.65

11.4

9.1

24.49

23.81

mmol/l

28.61

3643

8452

6386

12763

3.16

307.65

12.6

8.9

24.68

23.99

mmol/l

39.41

6216

12561

Any death

4448

13758

2.46

307.65

12.7

9.3

24.30

mmol/l

0.03

4326

13562

Diseases of arteries, arterioles and capillaries

4741

15226

2.47

307.65

12.1

9.0

24.09

24.32

mmol/l

4.38

4620

14858

Paroxysmal tachycardia

1126

2396

4.19

307.65

15.6

7.4

24.29

24.28

mmol/l

0.04

1095

2360

Other heart diseases, wide

5194

12673

2.62

307.65

14.2

9.1

24.29

24.19

mmol/l

1.24

5098

12440

Exposure to unspecified factor

5623

20595

1.94

307.65

11.4

9.7

24.30

24.23

mmol/l

0.77

5516

20092

Chronic kidney disease

2660

9279

3.09

307.65

13.5

8.1

22.87

24.51

mmol/l

88.79

2578

9018

3516

15466

2.15

307.65

13.2

9.9

24.13

24.16

mmol/l

0.22

3414

15134

Fever of other and unknown origin

3477

12237

2.62

307.65

11.3

9.7

24.21

24.17

mmol/l

0.25

3397

11976

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7107

16876

3.03

307.65

12.5

9.5

24.67

24.05

mmol/l

37.71

6903

16593

Malignant neoplasm of digestive organs

2621

8416

2.58

307.65

10.5

9.9

23.96

24.39

mmol/l

9.53

2598

8157

COPD, hospital admissions 3, with asthma pneumonia sepsis

2466

6967

3.48

307.65

9.5

9.0

25.24

24.00

mmol/l

47.46

2366

6785

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3425

17049

2.12

307.65

12.1

9.0

24.23

24.29

mmol/l

0.59

3365

16623

COPD, hospital admissions 1, only main diagnosis

2902

9133

3.08

307.65

9.2

8.9

25.26

24.06

mmol/l

54.86

2788

8906

COPD, hospital admission 2, with asthma infections

2814

8327

3.30

307.65

9.7

9.0

25.18

24.02

mmol/l

49.11

2705

8126

COPD, early/later onset

3794

11921

2.99

307.65

9.4

9.3

25.09

24.06

mmol/l

56.24

3660

11657

Dialysis, with operation codes

1425

3162

5.72

307.65

21.5

9.2

22.75

24.50

mmol/l

50.45

1386

3108

Aplastic and other anaemias

3081

13590

2.22

307.65

10.8

8.8

23.78

24.31

mmol/l

12.47

2967

13246

Implicit Sepsis

6093

15020

3.29

307.65

14.4

8.3

24.20

24.30

mmol/l

1.11

5930

14695

Hypertensive diseases (excluding secondary)

2657

3953

4.17

307.65

14.7

7.8

24.09

24.28

mmol/l

1.85

2616

3883

Provisional assignment of new diseases of uncertain etiology

3716

14683

2.72

307.65

14.3

8.9

24.53

24.16

mmol/l

8.75

3659

14317

Codes for special purposes

3720

14696

2.72

307.65

14.3

8.9

24.53

24.16

mmol/l

8.85

3662

14329

Transplanted organ and tissue status

1095

2164

6.46

307.65

29.9

10.0

23.22

24.35

mmol/l

23.21

1082

2126

Diabetes, varying definitions

5109

16244

1.89

307.65

13.2

8.9

23.99

24.40

mmol/l

13.42

4985

15879

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6139

18871

2.32

307.65

11.6

9.6

24.04

24.32

mmol/l

7.78

5969

18458

Later onset COPD, excluding more controls

1867

3766

4.38

307.65

8.2

7.7

24.99

23.78

mmol/l

33.93

1806

3713

Acute tubulo-interstitial nephritis

3772

14283

2.37

307.65

9.9

8.5

24.08

24.50

mmol/l

10.68

3659

13974

All chronic kidney diseases

4238

12257

3.03

307.65

12.4

8.6

23.27

24.52

mmol/l

81.51

4101

11982

Viral pneumonia

1040

2772

4.29

307.65

17.1

9.1

24.63

23.97

mmol/l

7.26

1020

2726

Other diseases of the respiratory system

1944

5769

3.94

307.65

12.6

8.7

25.92

24.08

mmol/l

75.90

1886

5595

Early onset COPD, excluding more controls

1737

4265

4.69

307.65

11.3

9.1

25.24

23.80

mmol/l

48.93

1688

4218

Implicit bacterial Sepsis, including avohilmo

4334

10766

3.82

307.65

14.7

7.9

24.19

24.29

mmol/l

0.80

4190

10509

Any gastric operation

3786

7528

2.63

307.65

12.3

7.8

24.18

24.29

mmol/l

1.12

3708

7336

Coronary revascularization (ANGIO or CABG)

4702

13339

2.27

307.65

15.1

8.7

24.19

24.37

mmol/l

3.04

4604

13086

Asthma, unspecified (mode), excluding more controls

3253

7024

3.57

307.65

9.7

8.4

24.69

23.82

mmol/l

36.62

3166

6937

Asthma (mode)

3739

8564

2.40

307.65

9.4

9.1

24.53

23.81

mmol/l

31.61

3652

8452

Major coronary heart disease event excluding revascularizations

3588

11734

2.14

307.65

12.1

8.5

24.06

24.37

mmol/l

5.64

3485

11481

Ulcer of lower limb, not elsewhere classified

1473

4173

4.24

307.65

12.6

9.1

24.19

24.24

mmol/l

0.21

1429

4063

Implicit viral Sepsis

1720

5143

3.79

307.65

14.1

8.0

24.31

mmol/l

0.01

1664

5009

Pneumonias (Asthma/COPD co-morbidities)

7318

16566

3.12

307.65

13.0

9.2

24.67

24.04

mmol/l

40.51

7115

16283

Complications of surgical and medical care, not elsewhere classified

6300

19185

2.32

307.65

11.9

9.2

24.21

24.26

mmol/l

0.65

6183

18693

Mental and behavioural disorders due to psychoactive substance use

3665

15982

2.23

307.65

12.3

10.1

24.30

24.15

mmol/l

1.55

3559

15645

Explicit Sepsis

3568

10774

3.35

307.65

14.8

8.0

23.84

24.28

mmol/l

9.47

3472

10516

Complications of procedures, not elsewhere classified

5016

18708

2.29

307.65

12.0

9.2

24.25

24.27

mmol/l

0.14

4923

18237

Substance abuse, excluding more controls

3592

12953

2.47

307.65

12.4

10.3

24.30

24.14

mmol/l

1.70

3486

12720

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

6275

15196

3.01

307.65

14.4

8.5

24.16

24.32

mmol/l

2.45

6138

14866

Hypertension

4079

9829

2.46

307.65

13.0

9.5

24.11

24.39

mmol/l

5.70

4009

9627

Bacterial infection, other or unspecified, including avohilmo

4797

13247

3.29

307.65

12.2

8.6

24.26

24.29

mmol/l

0.18

4634

12955

GASTRO-related operations

3786

7528

2.63

307.65

12.3

7.8

24.18

24.29

mmol/l

1.12

3708

7336

Coronary atherosclerosis

3815

11627

2.20

307.65

12.3

8.6

24.11

24.36

mmol/l

4.33

3727

11398

Atrial fibrillation and flutter

2000

2779

5.11

307.65

16.4

7.6

24.31

24.34

mmol/l

0.13

1972

2732

Covid-19 confirmed case

3099

10712

3.24

307.65

15.3

8.7

24.57

24.19

mmol/l

7.64

3057

10426

Erysipelas, including avohilmo

4731

14825

2.52

307.65

10.4

8.9

24.43

24.30

mmol/l

1.70

4587

14529

Percutaneous Coronary Intervention

4716

13333

2.28

307.65

14.9

8.7

24.19

24.37

mmol/l

3.09

4609

13080

Major coronary heart disease event

4905

14369

2.16

307.65

14.8

8.7

24.20

24.38

mmol/l

3.33

4802

14078

COPD

3909

10994

3.26

307.65

9.5

25.06

24.03

mmol/l

55.49

3770

10766

Atrial fibrillation and flutter with reimbursement

1741

2258

5.41

307.65

15.6

7.7

24.40

24.34

mmol/l

0.22

1715

2219

Atherosclerosis, excluding cerebral and coronary sclerosis

2881

10201

2.41

307.65

10.8

8.2

24.03

24.29

mmol/l

3.44

2786

9923

Pain in throat and chest

4440

12318

2.23

307.65

9.5

10.4

24.29

24.10

mmol/l

3.34

4312

12093

Heart failure, strict

5053

12131

3.26

307.65

12.7

8.9

24.46

24.21

mmol/l

4.66

4902

11885

Pulmonary heart disease, diseases of pulmonary circulation

2345

9475

2.72

307.65

11.1

9.0

24.64

24.26

mmol/l

6.29

2275

9216

Secondary hypertension

556

908

6.90

307.65

13.1

7.8

23.11

24.19

mmol/l

9.35

546

896

Hypothyroidism (congenital or acquired)

839

773

6.34

307.65

12.7

6.3

24.10

24.20

mmol/l

0.28

824

759

Hypertension, essential

4153

9661

2.56

307.65

11.6

9.4

24.14

24.40

mmol/l

4.72

4080

9459

L04AD Calcineurin inhibitors

1065

2429

5.37

307.65

26.7

11.0

23.12

24.35

mmol/l

27.32

1054

2398

Oxycodone

2828

8767

3.01

307.65

9.2

9.4

24.80

24.19

mmol/l

16.74

2756

8528

Hypothyroidism, levothyroxine purchases

819

770

6.22

307.65

12.7

6.3

24.10

24.20

mmol/l

0.30

804

757

Acute renal failure

2211

6405

4.07

307.65

20.3

8.2

22.84

24.51

mmol/l

55.78

2148

6241

Emergency coronary revascularization (for ACS)

5136

15089

2.17

307.65

14.4

8.7

24.20

24.36

mmol/l

2.76

5009

14764

Disorders of lipoprotein metabolism and other lipidaemias

4968

13856

2.31

307.65

10.7

9.2

24.19

24.36

mmol/l

2.94

4857

13539

Infections, IBD-co-morbidities

1010

1648

4.71

307.65

14.0

9.5

23.91

24.29

mmol/l

2.46

988

1615

Cardiovascular diseases

2589

4078

3.53

307.65

14.3

8.0

24.14

24.10

mmol/l

0.20

2547

4006

All-cause Heart Failure

4952

11955

3.24

307.65

12.3

8.8

24.47

24.21

mmol/l

4.71

4803

11712

Inflammatory bowel disease treatment related agents

5983

18308

1.88

307.65

10.7

10.0

24.47

24.11

mmol/l

12.87

5810

17904

Heart failure and antihypertensive medication

2310

2682

6.58

307.65

17.1

8.3

24.35

24.53

mmol/l

1.18

2265

2636

ILD, hospital admission 2, with pulmonary infections

904

2236

4.81

307.65

12.6

8.3

24.76

23.94

mmol/l

9.71

884

2184

ILD medications: prednisolone, methylprednisolone, prednisone

6226

16678

2.18

307.65

11.1

9.6

24.38

24.15

mmol/l

5.90

6050

16311

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

962

1252

6.28

307.65

12.9

9.6

24.68

24.35

mmol/l

1.77

933

1222

Heart failure and coronary heart disease

3436

8822

3.05

307.65

13.7

8.2

24.24

24.36

mmol/l

1.09

3318

8620

Pneumonia, organism unspecified

6709

15804

3.16

307.65

12.1

9.2

24.69

24.02

mmol/l

39.94

6509

15540

Valvular operations

1095

3132

3.98

307.65

17.7

8.3

24.20

24.17

mmol/l

0.10

1074

3081

Solid cancers, including Hilmo

4921

12675

2.39

307.65

9.8

10.8

24.24

24.34

mmol/l

1.37

4861

12324

Dental caries

1976

6299

3.28

307.65

15.3

10.2

23.94

24.23

mmol/l

3.33

1938

6176

Asthma (diagnoses ohter than nonallergic)

4829

20717

1.97

307.65

9.4

10.1

24.69

24.15

mmol/l

24.17

4688

20248

Caries of dentine

1714

5695

3.21

307.65

15.7

10.2

23.95

24.21

mmol/l

2.27

1682

5582

Tramadol

5610

11194

3.26

307.65

10.9

9.7

24.33

24.20

mmol/l

1.84

5498

10905

ILD medications

6220

16825

2.08

307.65

11.5

9.7

24.32

24.14

mmol/l

3.86

6049

16456

Bacterial pneumonia, not elsewhere classified

2697

8815

2.92

307.65

12.7

8.5

24.77

23.99

mmol/l

23.24

2597

8651

Codeine

4894

11619

2.38

307.65

9.4

9.7

24.22

24.19

mmol/l

0.24

4784

11324

Oral corticosteroids

5880

18002

2.00

307.65

10.2

9.9

24.57

24.12

mmol/l

19.40

5706

17602

Other chronic obstructive pulmonary disease, including avohilmo

4281

13795

2.82

307.65

9.5

25.01

24.08

mmol/l

53.12

4138

13497

Oedema, not elsewhere classified

2089

8217

2.67

307.65

9.7

9.2

24.48

24.21

mmol/l

2.76

2025

8033

Kidney transplant status

610

1147

7.07

307.65

16.8

13.2

22.47

24.35

mmol/l

32.72

601

1134

Type 2 diabetes, wide definition

4698

14358

2.18

307.65

11.8

8.8

24.05

24.44

mmol/l

10.61

4580

14029

Convulsions, not elsewhere classified

1554

5029

3.32

307.65

10.8

10.3

24.17

24.09

mmol/l

0.34

1524

4913

Pain in limb

4499

15173

1.96

307.65

9.7

10.4

24.31

24.22

mmol/l

0.98

4400

14806

Malaise and fatigue

3586

10711

2.84

307.65

9.9

9.5

24.51

24.18

mmol/l

6.05

3463

10477

Diseases of arteries, arterioles and capillaries (FINNGEN)

1993

2287

6.92

307.65

14.2

7.7

24.05

24.31

mmol/l

2.27

1965

2248

All kidney diseases

6572

17330

2.72

307.65

13.3

9.0

23.75

24.49

mmol/l

47.83

6418

16956

Codeine or tramadol medication

5994

17599

1.92

307.65

9.3

10.1

24.25

mmol/l

0.00

5858

17154

Other disorders of fluid, electrolyte and acid-base balance

2496

7891

3.32

307.65

12.9

8.3

24.05

24.39

mmol/l

3.50

2428

7679

Asthma-related pneumonia

2855

10319

3.05

307.65

10.8

9.0

24.93

24.14

mmol/l

25.77

2758

10043

Asthma, unspecified (mode)

3367

8151

3.20

307.65

9.6

8.9

24.69

23.81

mmol/l

38.45

3277

8043

Pure hypercholesterolaemia

4666

13385

2.35

307.65

10.2

9.1

24.16

24.35

mmol/l

3.36

4567

13076

Lung cancer and mesothelioma

1411

3736

3.57

307.65

8.3

8.4

24.87

23.73

mmol/l

35.05

1379

3691

Alcohol use disorder, Swedish definition

3408

14949

2.20

307.65

13.3

10.0

24.15

24.17

mmol/l

0.11

3307

14634

All pneumoniae

7326

16576

3.11

307.65

13.1

9.2

24.67

24.03

mmol/l

41.69

7128

16294

Substance abuse

3592

15752

2.25

307.65

12.4

10.2

24.30

24.15

mmol/l

1.53

3486

15423

Other pulmonary diagnosis

3725

8554

2.27

307.65

11.4

9.0

24.50

23.81

mmol/l

27.98

3648

8441

Non-ischemic cardiomyopathy

2481

6367

3.48

307.65

12.4

8.4

24.71

24.26

mmol/l

6.90

2423

6251

Valvular heart disease excluding rheumatic fever

3003

8173

2.83

307.65

13.3

8.5

24.21

mmol/l

0.02

2940

8021

Hernia of abdominal wall, postoperative

1188

3577

3.61

307.65

11.9

7.7

24.10

24.37

mmol/l

1.91

1173

3507

Other diseases of pleura

3647

12369

2.84

307.65

11.9

8.9

25.23

24.05

mmol/l

67.19

3546

12053

Other septicaemia

3074

9936

3.25

307.65

15.1

8.3

23.77

24.29

mmol/l

11.07

2991

9694

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6386

12763

3.16

307.65

12.6

8.9

24.68

23.99

mmol/l

39.41

6216

12561

Bacterial pneumoniae

2822

9289

2.90

307.65

12.7

8.6

24.74

24.00

mmol/l

22.55

2719

9118

Malignant neoplasm

4812

12673

2.35

307.65

10.0

10.8

24.24

24.34

mmol/l

1.36

4753

12323

Other bacterial diseases, including avohilmo

7104

16239

2.94

307.65

12.6

9.2

24.24

24.27

mmol/l

0.34

6905

15909

Heart failure and bmi 25plus

2702

6148

3.29

307.65

12.0

8.7

24.54

24.13

mmol/l

6.38

2611

6003

Renal tubulo-interstitial diseases

6364

17269

2.93

307.65

13.6

8.9

23.61

24.48

mmol/l

60.47

6197

16906

Other heart diseases

2936

4050

5.13

307.65

17.0

7.8

24.34

24.26

mmol/l

0.58

2891

3978

Cardiac arrhythmias

2871

6296

3.08

307.65

14.9

7.8

24.30

24.36

mmol/l

0.44

2820

6204

Hard cardiovascular diseases

5071

12774

2.50

307.65

15.2

8.6

24.24

24.38

mmol/l

2.09

4991

12531

Depression medications

976

811

6.31

307.65

11.1

5.9

24.21

mmol/l

0.01

960

797

COPD/asthma/ILD related infections

5151

12763

2.11

307.65

11.1

8.9

24.57

23.99

mmol/l

25.88

5031

12561

Other bacterial diseases

7073

16725

3.04

307.65

12.9

9.2

24.19

24.31

mmol/l

1.93

6877

16386

Opioids

5037

11721

2.32

307.65

10.9

9.7

24.20

24.18

mmol/l

0.21

4929

11419

Bacterial pneumonia (organism specified)

2982

11860

2.45

307.65

12.5

8.8

24.71

24.12

mmol/l

15.81

2872

11560

Influenza and pneumonia

7317

16210

3.00

307.65

12.9

9.2

24.66

24.02

mmol/l

41.85

7122

15939

Nephropathy related operations

1362

3180

5.43

307.65

21.9

10.1

22.75

24.31

mmol/l

39.25

1328

3126

Other septicaemia, including avohilmo

3163

10120

3.27

307.65

15.0

8.3

23.79

24.29

mmol/l

10.76

3079

9876

Malignant neoplasm, wide definition

4976

12821

2.39

307.65

10.1

10.9

24.23

24.34

mmol/l

1.45

4914

12466

Chronic lower respiratory diseases

6405

18109

1.94

307.65

9.9

10.4

24.65

24.04

mmol/l

37.89

6223

17734

Peripheral artery disease

3070

10852

2.42

307.65

11.0

8.3

24.05

24.29

mmol/l

2.99

2974

10560

Asthma, excluding more controls

3944

7311

2.92

307.65

9.9

8.5

24.67

23.83

mmol/l

41.18

3839

7220

Bacterial infection, other or unspecified

4484

12649

3.33

307.65

12.3

8.5

24.26

24.30

mmol/l

0.28

4326

12367

Asthma (only as main-diagnosis), excluding more controls

3575

7311

2.85

307.65

8.9

8.5

24.69

23.83

mmol/l

40.49

3485

7220

Fall on same level

5711

17539

1.79

307.32

10.9

10.1

24.30

24.17

mmol/l

2.03

5576

17137

Asthma/COPD (KELA code 203)

4856

18094

1.86

307.13

8.9

10.4

24.77

24.04

mmol/l

42.57

4716

17719

Other anaemias

2879

12987

2.22

305.80

10.7

8.8

23.80

24.32

mmol/l

11.07

2771

12657

Other and unspecified anaemias

2858

12903

2.23

305.47

10.7

8.8

23.79

24.32

mmol/l

11.52

2751

12575

Pulmonary embolism

2043

8617

2.59

305.27

11.0

9.1

24.58

24.24

mmol/l

4.60

1982

8385

ILD, hospital admissions 3, with pneumonia sepsis

796

1971

4.84

302.57

12.4

8.3

24.78

23.93

mmol/l

8.69

778

1931

Type 2 diabetes

4905

15818

1.86

301.70

12.9

8.8

24.06

24.41

mmol/l

9.47

4786

15462

Venous thromboembolism

3300

16171

2.08

301.62

10.3

9.0

24.46

24.25

mmol/l

3.18

3215

15748

Unspecified kidney failure

978

2810

4.11

300.95

12.1

8.2

23.10

24.53

mmol/l

21.75

933

2729

Cardiomyopathy

1198

3860

3.45

300.17

17.5

8.3

24.06

24.16

mmol/l

0.37

1163

3796

Pulmonary heart disease

2043

8704

2.56

298.56

11.0

9.1

24.58

24.26

mmol/l

4.26

1982

8470

Substance use, excluding alcohol

1289

4346

3.25

297.59

11.0

10.6

24.74

24.20

mmol/l

6.35

1247

4271

Stroke, including SAH

3846

14601

2.00

297.32

11.1

9.3

24.29

mmol/l

0.04

3752

14230

Later onset COPD

2078

7102

2.59

293.25

7.8

8.0

24.96

24.01

mmol/l

25.90

1992

6903

Other diseases of intestines

5142

16283

1.82

292.29

10.7

10.1

24.14

24.24

mmol/l

1.37

5035

15895

L04AA Selective immunosuppressants

1479

5445

2.99

292.22

19.9

10.2

23.53

24.32

mmol/l

15.72

1458

5359

Poisoning by drugs, medicaments and biological substances

1396

4979

3.03

289.59

11.3

10.7

24.36

24.21

mmol/l

0.78

1359

4893

Mental and behavioural disorders due to alcohol

3016

14342

2.12

289.00

12.8

10.2

24.21

24.14

mmol/l

0.52

2929

14042

Other nutritional deficiencies

3512

16799

2.00

288.63

11.6

10.2

24.65

24.19

mmol/l

11.70

3422

16484

Obesity

3314

16164

2.02

282.84

11.5

10.2

24.67

24.19

mmol/l

12.19

3229

15864

2453

11342

2.26

282.67

9.4

10.3

24.85

24.13

mmol/l

22.33

2378

11109

Myocardial infarction, strict

2779

9431

2.23

282.07

11.9

8.5

23.92

24.34

mmol/l

8.22

2698

9238

Obesity and other hyperalimentation

3323

16229

2.01

281.21

11.5

10.2

24.67

24.19

mmol/l

12.37

3238

15928

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4703

15744

1.84

279.07

12.1

8.9

23.98

24.43

mmol/l

13.54

4582

15393

Other soft tissue disorders, not elsewhere classified

4781

15390

1.83

278.22

9.8

10.4

24.24

24.22

mmol/l

0.21

4673

15016

DVT of lower extremities and pulmonary embolism

2634

12743

2.20

276.52

10.4

9.0

24.49

24.26

mmol/l

3.28

2561

12400

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2704

13141

2.17

275.58

13.0

10.4

24.22

24.17

mmol/l

0.26

2621

12868

Poisoning by medicine

1265

4415

3.11

273.24

11.5

10.8

24.39

24.20

mmol/l

1.03

1233

4338

Intracranial trauma

2753

8889

2.17

271.73

10.6

10.2

24.20

24.09

mmol/l

0.95

2690

8685

Colorectal cancer

1621

6244

2.72

266.70

8.7

9.1

23.85

24.38

mmol/l

9.69

1608

6045

Malignant neoplasm of urinary organs, including Hilmo

939

2834

3.82

266.09

8.9

9.8

23.39

24.34

mmol/l

16.86

924

2750

Other respiratory diseases principally affecting the interstitium

1395

5289

2.96

264.03

11.9

9.1

24.63

24.23

mmol/l

4.17

1355

5143

All influenza

1553

6143

2.72

262.84

10.2

8.9

24.63

23.98

mmol/l

10.60

1504

6023

Diverticular disease of intestine

3945

13456

1.91

262.70

9.7

9.6

24.28

24.31

mmol/l

0.26

3843

13136

Hypo-osmolality and hyponatraemia

1238

4354

3.12

262.53

13.7

8.2

24.24

24.44

mmol/l

1.08

1210

4231

Insulin, intermediate and long-acting

3246

16672

1.98

259.33

12.9

9.3

23.77

24.28

mmol/l

11.42

3142

16285

Symptoms and signs involving the urinary system

4189

17916

1.84

259.18

9.5

9.8

24.22

24.29

mmol/l

0.59

4084

17494

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1376

5074

2.84

257.95

11.2

10.3

24.22

24.11

mmol/l

0.58

1343

5005

Iron deficiency anaemia

2571

12432

2.15

257.37

11.4

8.7

24.04

24.29

mmol/l

3.02

2494

12105

Nutritional anaemias

2921

14362

2.05

255.57

11.1

8.6

24.01

24.30

mmol/l

4.13

2831

13981

Pain, not elsewhere classified

1570

6313

2.65

255.42

10.5

9.4

24.59

24.19

mmol/l

5.26

1534

6186

Presence of cardiac and vascular implants and grafts

2903

10885

2.09

253.08

13.3

8.7

24.14

24.30

mmol/l

1.76

2818

10601

Diseases of oesophagus, stomach and duodenum

5316

18851

1.72

252.71

11.4

9.7

24.19

24.28

mmol/l

1.05

5181

18424

Other acute lower respiratory infections

3006

14948

2.01

251.98

10.1

9.7

24.64

24.16

mmol/l

11.54

2902

14571

Other and unspecified iron deficiency

2099

9656

2.32

251.92

11.1

8.6

24.09

24.31

mmol/l

2.04

2036

9410

Obesity related asthma

2029

9221

2.35

251.90

10.0

24.93

24.16

mmol/l

19.70

1978

9076

Need for other prophylactic measures

577

1298

5.53

250.26

15.5

10.9

24.45

24.26

mmol/l

0.70

571

1277

Stroke, excluding SAH

3580

14138

1.93

249.81

10.9

9.3

24.27

24.29

mmol/l

0.10

3485

13777

Hypothyroidism, drug reimbursement

461

487

6.94

249.10

10.9

6.2

24.36

24.26

mmol/l

0.23

449

477

Insulin, combination of fast acting with intermediate-acting or long-acting

3525

17623

1.90

248.62

13.2

9.3

23.81

24.28

mmol/l

10.72

3415

17200

Type 2 diabetes, definitions combined

4593

15503

1.78

246.74

12.1

8.8

24.14

24.42

mmol/l

6.32

4488

15153

Peripheral arterial reconstruction

1333

5117

2.93

246.69

12.3

8.6

23.93

24.21

mmol/l

2.13

1291

4951

Colorectal adenocarcinoma

1397

5377

2.82

246.35

8.7

9.1

23.88

24.35

mmol/l

6.89

1385

5206

Medical observation and evaluation for suspected diseases and conditions

3303

8740

2.01

245.87

10.0

10.3

24.29

mmol/l

0.02

3214

8543

Non-invasive ventilation

1052

2941

3.25

245.53

10.3

6.9

25.68

24.18

mmol/l

30.37

1015

2904

Obesity, other/unspecified

1802

7858

2.43

245.07

11.2

10.2

24.71

24.16

mmol/l

9.08

1755

7740

Type 2 diabetes, strict (exclude DM1)

4612

15646

1.77

243.47

12.2

8.9

24.14

24.42

mmol/l

6.29

4507

15294

Cardiac arrest

475

725

6.33

243.27

19.5

7.4

23.77

24.20

mmol/l

1.35

461

713

Malignant neoplasm of brain

405

687

7.77

242.08

5.5

10.8

24.42

24.37

mmol/l

0.14

405

677

867

2608

3.64

241.41

13.6

9.9

24.44

24.28

mmol/l

0.64

842

2565

Preparatory care for dialysis

507

1072

6.34

241.27

14.5

10.8

22.67

24.31

mmol/l

18.96

490

1058

Mood disorders, excluding more controls

4594

15775

1.77

241.18

10.2

10.0

24.35

24.22

mmol/l

1.68

4465

15476

Unspecified privation

850

2561

3.81

241.09

12.4

9.8

24.32

24.20

mmol/l

0.43

828

2513

Alcohol use disorder, ICD-based

2463

12270

2.13

240.87

13.0

10.5

24.22

24.18

mmol/l

0.19

2386

12014

Invasive ventilation

673

1751

4.63

240.10

19.8

10.1

24.40

24.16

mmol/l

0.79

650

1719

Other disorders of urethra and urinary system

3563

13608

1.89

239.91

8.9

9.5

24.33

24.23

mmol/l

0.97

3478

13280

Paralytic ileus and intestinal obstruction

1664

7104

2.52

239.78

12.2

9.0

24.24

24.29

mmol/l

0.21

1632

6914

Diabetes, insulin treatment (Kela reimbursement)

5054

18150

1.71

236.84

12.1

9.3

23.99

24.39

mmol/l

11.91

4925

17736

Acute bronchitis

2365

11423

2.14

236.39

9.5

9.3

24.68

24.17

mmol/l

10.10

2278

11112

Epilepsy

1839

8211

2.38

235.79

8.6

10.1

24.26

24.12

mmol/l

1.02

1802

7996

Other interstitial pulmonary diseases

1203

4494

3.03

235.25

11.4

9.2

24.66

24.24

mmol/l

3.85

1170

4385

Diabetes medication

5031

17711

1.71

235.16

12.2

9.2

24.02

24.38

mmol/l

10.05

4900

17317

Symptoms and signs involving cognition, perception, emotional state and behaviour

4852

19519

1.72

234.77

9.0

10.3

24.43

24.20

mmol/l

5.14

4714

19101

Interstitial lung disease

1203

4511

3.02

233.56

11.4

9.2

24.66

24.24

mmol/l

3.86

1170

4400

Interstitial lung disease endpoints

1203

4511

3.02

233.56

11.4

9.2

24.66

24.24

mmol/l

3.86

1170

4400

ILD, hospital admissions

1185

4412

3.04

233.35

11.5

9.2

24.67

24.23

mmol/l

4.19

1152

4305

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1589

5456

2.61

233.12

8.9

9.3

24.87

24.31

mmol/l

9.92

1555

5287

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

809

2417

3.87

233.06

8.9

9.9

23.44

24.34

mmol/l

13.76

800

2355

Use of hypnotics and sedatives

5301

18564

1.68

232.12

9.9

10.2

24.25

24.24

mmol/l

0.10

5170

18156

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1450

2657

2.84

231.78

10.6

24.36

24.06

mmol/l

2.55

1426

2616

Diarrhoea and gastroenteritis of presumed infectious origin

3605

18178

1.84

231.37

11.5

9.6

24.11

24.25

mmol/l

1.46

3493

17740

Gout

1932

7592

2.36

231.33

11.2

9.8

23.78

24.28

mmol/l

7.25

1884

7377

Certain infectious and parasitic diseases, including avohilmo

3290

8676

1.96

231.12

10.7

9.1

24.28

24.21

mmol/l

0.55

3208

8519

Malignant neoplasm of urinary organs

795

2365

3.89

230.59

9.2

9.7

23.34

24.31

mmol/l

15.08

788

2297

Type 2 diabetes, definitions combined, including avohilmo

4526

15425

1.75

229.25

12.2

8.9

24.15

24.41

mmol/l

5.53

4423

15084

Benzodiazepine use

5026

20761

1.69

228.55

9.3

10.1

24.48

24.19

mmol/l

7.54

4879

20302

Bronchitis

5380

19979

1.66

227.87

10.0

9.7

24.58

24.16

mmol/l

16.07

5214

19535

Extracorporeal dialysis

608

1540

4.93

227.64

19.6

11.4

22.88

24.19

mmol/l

15.32

588

1517

Other disorders of skin and subcutaneous tissue

3901

19131

1.79

226.24

10.3

9.5

24.27

24.28

mmol/l

0.09

3785

18695

Personality disorders, excluding more controls

1226

4618

2.80

225.50

10.6

10.7

24.49

24.13

mmol/l

3.04

1186

4563

Conduction disorders

1647

5634

2.49

225.17

11.6

8.0

24.19

24.20

mmol/l

0.05

1605

5538

Nausea and vomiting

1612

6779

2.47

224.62

11.3

9.1

24.19

24.27

mmol/l

0.35

1569

6610

Injuries to the head

5463

20209

1.65

224.26

10.5

10.0

24.24

24.23

mmol/l

0.04

5336

19733

Infections of the skin and subcutaneous tissue

3109

16807

1.90

223.32

12.2

10.2

24.14

24.22

mmol/l

0.58

3031

16452

Polyarthropathies

3454

12287

1.88

222.43

10.9

10.6

24.05

24.28

mmol/l

3.34

3377

11982

Care involving use of rehabilitation procedures

3138

15495

1.89

221.42

11.3

9.6

24.33

24.27

mmol/l

0.49

3075

15124

Intestinal stricture

1968

9344

2.26

220.77

13.0

8.9

24.12

24.30

mmol/l

1.46

1936

9096

Sequelae of external causes of morbidity and mortality

1641

7243

2.45

220.54

13.4

9.3

24.31

24.28

mmol/l

0.10

1626

7090

Intestinal infectious diseases

4695

21298

1.69

219.94

11.3

9.8

24.10

24.27

mmol/l

2.66

4558

20814

Malignant neoplasm of kidney, except renal pelvis

730

2137

3.97

217.34

8.9

9.9

23.43

24.34

mmol/l

12.96

724

2084

Explicit bacterial Sepsis, including avohilmo

805

2492

3.64

216.90

14.0

8.1

24.11

24.29

mmol/l

0.67

781

2425

Glomerular disorders in diseases classified elsewhere

908

3041

3.41

216.88

15.2

10.3

22.82

24.23

mmol/l

24.60

882

2984

5430

17143

1.65

216.03

9.7

9.5

24.56

24.11

mmol/l

18.28

5279

16770

ILD, hospital admissions 1, main diag only

1069

3933

3.09

215.84

11.5

9.2

24.68

24.24

mmol/l

3.79

1040

3837

Myocardial infarction, without ST-elevation

2562

12129

2.03

213.87

11.5

8.7

24.00

24.29

mmol/l

3.91

2469

11800

Disorders of gallbladder, biliary tract and pancreas

4967

19137

1.67

212.94

11.4

9.5

24.11

24.29

mmol/l

3.23

4863

18659

Asthma, hospital admissions , main diagnosis only

4025

20855

1.74

212.52

8.8

10.2

24.70

24.17

mmol/l

20.01

3919

20366

Other diseases of urinary system

4806

16482

1.69

211.74

9.5

10.2

24.20

24.21

mmol/l

0.08

4695

16106

Glomerular diseases

1226

4862

2.78

210.37

14.2

10.0

23.07

24.27

mmol/l

25.22

1194

4753

Colectomy operation

1190

4663

2.84

210.16

12.2

9.3

23.72

24.30

mmol/l

7.82

1181

4556

Diseases of the respiratory system

2790

7192

2.01

209.27

10.8

9.0

24.45

23.81

mmol/l

19.25

2735

7094

Benign neoplasm of colon, rectum, anus and anal canal

3607

17762

1.80

209.17

9.4

9.5

24.16

24.31

mmol/l

1.95

3505

17353

Asthma, including avohilmo

5683

19984

1.61

207.75

9.3

10.3

24.61

24.11

mmol/l

24.04

5540

19522

Syncope and collapse

2368

10078

2.05

207.38

9.6

9.5

24.24

24.19

mmol/l

0.26

2296

9848

Viral hepatitis, IBD co-morbidity

354

592

6.70

206.64

13.6

9.5

24.34

24.23

mmol/l

0.20

348

581

Streptococcal septicaemia, including avohilmo

719

2150

3.83

206.09

14.3

8.8

24.08

24.26

mmol/l

0.66

700

2110

Other diseases of the digestive system

2025

9977

2.17

205.38

12.0

8.8

24.05

24.24

mmol/l

1.48

1976

9690

Implicit fungal Sepsis, including avohilmo

591

1562

4.43

204.37

15.3

8.1

24.36

24.37

mmol/l

0.02

574

1528

GI-bleeding

2021

9989

2.16

203.02

11.9

8.8

24.06

24.22

mmol/l

1.25

1968

9700

Diseases of liver

2037

10095

2.15

202.76

14.0

9.7

23.77

24.32

mmol/l

8.94

1989

9888

Viral pneumonia (unknown virus, not influenza)

565

1454

4.55

202.70

22.7

11.0

24.68

24.10

mmol/l

3.67

556

1430

Explicit bacterial Sepsis

773

2439

3.56

201.82

13.4

8.2

24.12

24.31

mmol/l

0.69

751

2374

Any mental disorder

5157

16183

1.64

199.80

10.2

10.0

24.33

24.22

mmol/l

1.52

5018

15870

Vocal cord dysfunction

652

1576

3.88

198.64

13.2

6.7

24.72

24.39

mmol/l

1.83

638

1555

Follow-up examination after treatment for conditions other than malignant neoplasms

2216

7336

2.10

197.96

9.6

10.1

24.28

24.31

mmol/l

0.21

2186

7186

Gout, idiopatic and unspecified

1719

8118

2.31

197.78

11.2

9.3

23.78

24.23

mmol/l

5.47

1675

7905

Emphysema

639

1836

4.08

196.41

9.7

9.9

24.68

23.92

mmol/l

5.73

623

1800

Diseases of the digestive system

2619

14151

1.93

195.87

12.0

9.1

24.05

24.26

mmol/l

2.18

2550

13778

Calcific aortic valvular stenosis

1943

9248

2.18

195.21

9.8

8.4

24.22

24.26

mmol/l

0.19

1898

8942

Calcific aortic valvular stenosis, operated

1943

9248

2.18

195.21

9.8

8.4

24.22

24.26

mmol/l

0.19

1898

8942

Ischaemic Stroke, excluding all haemorrhages

3235

13645

1.83

194.39

10.3

9.2

24.24

24.30

mmol/l

0.38

3139

13294

Calcific aortic valvular stenosis, diagnosis (helper)

1939

9239

2.17

194.20

9.7

8.3

24.22

24.26

mmol/l

0.18

1894

8933

Operations 2 for CAVS

1939

9239

2.17

194.20

9.7

8.3

24.22

24.26

mmol/l

0.18

1894

8933

Obesity due to excess calories

2336

12267

1.99

193.91

11.3

10.1

24.60

24.18

mmol/l

6.91

2272

12071

Hypokalaemia

816

2720

3.33

193.58

12.7

8.6

25.05

24.40

mmol/l

4.28

791

2662

Calcific aortic valvular stenosis, including rheumatic fever

1942

9272

2.17

192.78

9.7

8.3

24.22

24.26

mmol/l

0.17

1897

8964

Artificial opening status

526

1348

4.78

192.74

16.6

9.8

24.06

24.31

mmol/l

0.85

517

1320

Streptococcal septicaemia

690

2104

3.74

191.68

13.7

8.9

24.07

24.25

mmol/l

0.59

671

2065

Sequelae with surgical and medical care as external cause

1316

5623

2.55

191.52

13.5

9.4

24.31

24.30

mmol/l

0.01

1303

5507

Cardiomyopathy (excluding other)

814

2728

3.31

191.22

19.8

8.8

24.00

24.15

mmol/l

0.56

788

2685

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

902

3190

3.06

190.28

12.2

11.2

24.21

24.26

mmol/l

0.17

881

3143

Malignant neoplasm of bronchus and lung, including Hilmo

1375

4923

2.53

190.11

8.2

9.0

24.84

24.33

mmol/l

7.78

1345

4762

Peripheral artery operations in Hilmo

940

3435

3.05

189.92

13.2

8.6

23.95

24.21

mmol/l

1.32

912

3320

Other antidepressants

4886

15646

1.64

189.36

10.0

10.1

24.39

24.14

mmol/l

5.52

4746

15310

Intestinal infectious diseases, including avohilmo, including avohilmo

5522

19975

1.58

188.03

10.9

9.8

24.20

24.27

mmol/l

0.74

5367

19530

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1376

5983

2.42

187.70

11.2

10.6

24.22

24.14

mmol/l

0.36

1343

5877

Headache

2855

12254

1.86

187.30

9.1

9.9

24.36

24.20

mmol/l

2.05

2787

12004

Insulin, fast-acting

2001

10114

2.09

187.26

13.8

9.5

23.72

24.28

mmol/l

8.47

1931

9899

Gout, FINNGEN

1932

9647

2.14

186.60

11.2

9.1

23.78

24.21

mmol/l

5.90

1884

9378

Cardiomyopathies, Primary/intrinsic

785

2622

3.32

185.52

20.0

8.6

23.97

24.12

mmol/l

0.55

761

2582

Other arrhythmias

2713

11097

1.89

185.39

11.2

8.8

24.36

24.22

mmol/l

1.57

2646

10900

Suicide or other Intentional self-harm

1273

5403

2.51

184.81

11.6

10.7

24.29

24.19

mmol/l

0.46

1242

5312

Other diseases of intestine

1043

4064

2.82

184.79

14.2

9.9

23.99

24.32

mmol/l

2.76

1024

3976

Mood [affective] disorders

4812

19606

1.62

184.74

10.4

10.1

24.34

24.25

mmol/l

1.11

4675

19189

Mood disorders

4818

19625

1.61

183.75

10.4

10.1

24.35

24.25

mmol/l

1.15

4681

19205

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3082

13928

1.82

183.54

10.8

9.0

23.84

24.39

mmol/l

13.34

2986

13603

Statin medication

2761

8426

1.90

182.82

12.9

9.1

24.10

24.43

mmol/l

5.20

2696

8234

Hernia

4485

18735

1.64

182.66

10.4

9.9

24.30

24.28

mmol/l

0.17

4373

18292

Malignant neoplasm of respiratory system and intrathoracic organs

1362

4915

2.49

182.36

8.8

9.2

24.90

24.29

mmol/l

10.11

1335

4758

Anxiety disorders, excluding more controls

3739

14322

1.72

181.61

10.0

10.2

24.41

24.26

mmol/l

2.02

3631

14071

Neurological diseases, wide definition

1143

2106

2.82

181.61

11.5

11.1

24.22

24.24

mmol/l

0.07

1127

2063

AV-block

1071

3562

2.77

181.52

12.3

7.5

24.11

24.20

mmol/l

0.37

1045

3490

Dialysis

394

848

5.86

180.92

14.4

10.8

22.34

24.51

mmol/l

25.71

386

834

Coronary artery bypass grafting

1601

5522

2.32

178.69

13.8

8.1

24.00

24.25

mmol/l

2.26

1571

5394

Hyperlipidaemia, other/unspecified

2119

9921

2.02

178.49

10.4

8.7

24.09

24.37

mmol/l

3.27

2060

9673

Gout, unspecified

1424

6507

2.40

178.40

11.0

9.4

23.72

24.23

mmol/l

5.61

1386

6340

Diaphragmatic hernia

2028

10499

2.05

178.15

10.1

8.9

24.28

24.33

mmol/l

0.30

1982

10248

Injuries to the hip and thigh

2722

13762

1.86

177.93

9.1

9.0

24.38

24.24

mmol/l

1.25

2656

13395

Aneurysms, operations, SAH

1036

4101

2.76

177.57

10.0

9.2

24.25

24.31

mmol/l

0.26

1025

4017

Retention of urine

2104

8826

2.05

177.22

8.7

9.5

24.07

24.20

mmol/l

0.92

2036

8594

Falls/tendency to fall

4749

15038

1.62

176.83

10.8

10.1

24.26

24.16

mmol/l

1.22

4647

14684

Fracture of femur

1706

7469

2.20

176.21

8.7

8.2

24.36

24.30

mmol/l

0.27

1662

7214

Non-small cell lung cancer, including Hilmo

1021

3764

2.79

175.46

8.7

9.0

24.92

24.27

mmol/l

10.29

1006

3631

Hyperkalaemia

511

1366

4.40

174.43

12.2

7.8

23.20

24.35

mmol/l

6.84

493

1326

Benign neoplasm: Colon

3056

16876

1.78

174.26

9.5

9.4

24.12

24.31

mmol/l

2.41

2969

16492

Osteopathies and chondropathies

2908

15387

1.80

173.39

10.2

9.5

24.43

24.29

mmol/l

1.30

2823

15044

Extreme obesity with alveolar hypoventilation

405

924

5.50

173.33

10.1

10.3

26.78

24.24

mmol/l

28.52

396

910

Malignant neoplasm of colon, including Hilmo

1154

4833

2.58

173.10

8.9

23.77

24.35

mmol/l

8.56

1138

4672

Malignant neoplasm of rectum, including Hilmo

825

2964

3.10

171.98

8.7

10.0

23.94

24.29

mmol/l

2.70

817

2887

Focal epilepsy

1260

5528

2.45

171.09

8.0

10.2

24.24

24.21

mmol/l

0.11

1242

5402

Depression

4390

18653

1.62

170.56

10.5

10.2

24.31

24.25

mmol/l

0.50

4268

18281

Other (not insulin) diabetes medications

4558

17076

1.61

169.56

11.0

9.1

24.14

24.39

mmol/l

4.93

4445

16693

Problems related to lifestyle

639

1984

3.53

169.52

11.9

10.8

24.36

24.22

mmol/l

0.43

625

1952

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1037

4227

2.73

169.13

14.9

10.6

23.42

24.27

mmol/l

9.48

1008

4150

Benign neoplasms

4464

15368

1.62

169.09

9.7

10.6

24.17

24.19

mmol/l

0.13

4359

14991

Other or unspecified ileus, impaction or obstruction

1156

4911

2.54

169.06

11.2

9.0

24.15

24.30

mmol/l

0.71

1136

4776

Cardiodefibrillation

2161

11670

1.97

167.36

13.6

9.1

24.23

24.25

mmol/l

0.06

2086

11401

Non-allergic asthma (mode), excluding more controls

873

3196

2.86

167.36

9.6

7.6

24.81

23.79

mmol/l

16.06

848

3157

Other anxiety disorders

2014

8883

2.00

167.30

10.7

10.6

24.46

24.18

mmol/l

3.62

1951

8737

Anxiety (asthma-related co-morbidities)

2561

10839

1.85

166.53

10.4

10.5

24.40

24.24

mmol/l

1.76

2480

10672

Insulin, fast-acting or short human

2011

10620

1.99

165.47

13.8

9.8

23.72

24.25

mmol/l

7.76

1940

10382

Episodal and paroxysmal disorders

4886

16032

1.58

165.45

9.8

10.3

24.35

24.14

mmol/l

4.42

4785

15628

Chronic periodontitis, including avohilmo

4769

19825

1.58

165.40

11.0

9.7

24.26

24.27

mmol/l

0.08

4679

19376

Periodontitis

4773

19827

1.58

165.20

11.0

9.7

24.26

24.27

mmol/l

0.06

4683

19378

Focal epilepsy, strict definition

1190

5180

2.48

164.96

8.0

10.2

24.28

24.24

mmol/l

0.21

1173

5063

Brain glioblastoma and astrocytoma

237

348

9.69

164.58

5.0

9.1

24.46

24.47

mmol/l

0.02

237

343

Constipation

4411

19211

1.60

164.46

9.4

10.0

24.46

24.21

mmol/l

5.37

4294

18778

Cardiomyopathy, other and unspecified

529

1510

3.96

162.01

16.3

8.5

24.10

24.25

mmol/l

0.39

512

1490

Injuries to the abdomen, lower back, lumbar spine and pelvis

2196

11820

1.92

161.96

10.1

9.2

24.42

24.23

mmol/l

1.66

2138

11510

Cystitis

3879

14342

1.65

161.50

9.0

9.8

24.28

24.23

mmol/l

0.49

3779

14001

Alcohol dependence

1549

7557

2.19

161.16

11.9

10.3

24.41

24.17

mmol/l

1.67

1494

7388

Gastrointestinal diseases

2329

6168

1.94

161.12

11.2

8.8

24.17

24.29

mmol/l

0.99

2290

6034

Amputation

765

2754

3.13

160.06

14.3

9.4

23.94

24.22

mmol/l

1.23

745

2670

Benign neoplasm of meninges

726

2541

3.22

159.87

6.2

8.6

24.22

24.38

mmol/l

0.73

719

2491

Aortic aneurysm

1472

6948

2.23

159.20

12.6

8.8

24.14

24.17

mmol/l

0.12

1440

6761

Cutaneous abscess, furuncle and carbuncle

1411

6679

2.24

157.85

13.5

10.4

24.22

24.21

mmol/l

0.07

1374

6558

Cerebral aneurysm, nonruptured

608

1937

3.55

157.24

7.2

9.4

24.20

24.35

mmol/l

0.56

603

1906

Gout, strict definition

1259

5772

2.39

156.80

10.9

9.5

23.69

24.23

mmol/l

5.43

1223

5634

Undetermined asthma, excluding more controls

651

2135

3.26

155.79

9.0

7.6

24.59

23.79

mmol/l

8.29

628

2109

Other reaction to severe stress, and adjustment disorders

1553

7611

2.12

155.64

11.2

10.4

24.26

24.20

mmol/l

0.33

1518

7494

Focal epilepsy, mode (most common among epilepsy diagnosis)

1114

4834

2.49

155.48

8.1

10.1

24.27

24.23

mmol/l

0.16

1100

4727

Injuries to the thorax

2527

14576

1.81

155.35

11.2

9.6

24.30

24.24

mmol/l

0.44

2475

14211

Other pulmonary heart/vessel disease

431

1121

4.69

154.83

15.9

9.6

24.93

24.23

mmol/l

3.37

418

1092

Amiodarone users

772

2860

3.09

154.69

21.8

9.5

24.29

24.21

mmol/l

0.28

751

2809

Symptoms and signs involving the digestive system and abdomen

4592

14910

1.58

154.23

10.8

10.1

24.24

24.21

mmol/l

0.27

4481

14562

Personality disorders

1226

5519

2.34

154.16

10.6

11.0

24.49

24.17

mmol/l

2.60

1186

5437

Unspecified haematuria

2387

11036

1.85

150.78

10.3

9.7

24.00

24.25

mmol/l

3.22

2326

10768

Benign neoplasm: Cerebral meninges

669

2316

3.27

150.50

6.2

8.6

24.20

24.39

mmol/l

0.95

663

2270

Concussion

2109

8852

1.90

150.43

9.6

10.2

24.25

24.09

mmol/l

1.36

2059

8650

Idiopathic pulmonary fibrosis

638

2168

3.42

150.14

11.2

8.8

24.92

24.17

mmol/l

6.68

614

2114

Biguanides

4460

17623

1.57

149.65

10.9

9.4

24.13

24.36

mmol/l

4.32

4343

17221

Chronic periodontitis, complicated

2944

17432

1.71

148.94

11.8

9.8

24.23

24.29

mmol/l

0.41

2893

17090

Disorders of thyroid, IBD co-morbidities

733

1699

3.09

148.83

12.6

8.9

24.45

24.22

mmol/l

1.06

723

1663

Alcohol abuse, main dg, excluding more controls

860

3376

2.75

148.70

13.1

10.4

24.27

24.16

mmol/l

0.41

838

3334

Spondylopathies

3832

14353

1.63

148.19

8.4

10.3

24.30

24.20

mmol/l

1.06

3752

14007

Low back pain

3598

15253

1.64

147.37

9.1

10.5

24.52

24.17

mmol/l

8.60

3518

14895

Disorders of adult personality and behaviour

1255

5813

2.26

146.87

10.2

11.0

24.54

24.16

mmol/l

3.61

1215

5725

Diabetic nephropathy, excluding more controls

1043

3637

2.59

146.86

14.1

12.2

23.13

24.11

mmol/l

12.73

1010

3554

Secondary right heart disease

398

1020

4.80

146.27

15.7

8.8

24.94

24.22

mmol/l

3.24

387

993

Malignant neoplasm of bronchus and lung

1160

4335

2.41

146.09

8.0

8.7

24.87

24.30

mmol/l

7.94

1136

4192

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

692

2473

3.12

145.95

8.7

10.1

23.94

24.32

mmol/l

2.63

687

2412

Pain in joint

2689

9588

1.78

145.91

9.3

10.7

24.26

24.20

mmol/l

0.46

2643

9376

Volume depletion

652

2254

3.20

145.27

11.1

8.5

23.91

24.34

mmol/l

1.70

625

2175

Other external causes of accidental injury

3440

10560

1.67

145.15

10.2

9.8

24.28

24.14

mmol/l

1.64

3371

10290

Adenocarcinoma and papilloma adenocarcinoma of rectum

671

2366

3.17

145.12

8.7

10.0

23.93

24.33

mmol/l

2.76

666

2307

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

427

1131

4.20

144.62

12.1

11.6

24.55

24.14

mmol/l

1.54

418

1110

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4689

20105

1.53

143.70

11.1

9.8

24.19

24.27

mmol/l

0.83

4552

19655

Angina pectoris

2744

10778

1.76

142.81

10.6

8.6

24.22

24.36

mmol/l

1.25

2669

10562

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

895

3561

2.62

140.17

16.3

10.9

23.82

24.22

mmol/l

3.65

889

3500

Unspecified fall

2613

15336

1.74

139.93

11.2

9.6

24.38

24.23

mmol/l

1.34

2548

14955

Spinal stenosis

2754

12199

1.73

138.85

7.9

9.8

24.28

24.22

mmol/l

0.37

2692

11903

Accidents

3407

10560

1.66

138.42

10.1

9.8

24.29

24.14

mmol/l

1.82

3342

10290

Autoimmune diseases excluding thyroid diseases

4800

17519

1.52

137.35

11.1

9.9

24.06

24.27

mmol/l

3.95

4678

17125

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

939

3860

2.54

137.34

16.1

11.1

23.86

24.22

mmol/l

3.11

930

3790

Autoimmune diseases excluding thyroid diseases, strict definition

4644

16912

1.53

136.72

11.1

9.8

24.06

24.26

mmol/l

3.44

4526

16529

All anxiety disorders

2592

11911

1.74

136.66

10.4

10.8

24.39

24.24

mmol/l

1.62

2510

11718

Disorders of lens

3332

12973

1.65

136.03

11.3

10.3

24.23

24.26

mmol/l

0.23

3258

12726

Non-allergic asthma (mode)

873

3543

2.57

135.86

9.6

8.3

24.81

23.79

mmol/l

16.13

848

3498

Malignant neoplasm of colon

925

3936

2.54

135.38

8.7

9.2

23.79

24.33

mmol/l

6.26

916

3818

Type 1 diabetes

1206

5686

2.23

134.95

14.2

9.0

23.41

24.38

mmol/l

14.53

1167

5566

ILD-related respiratory insufficiency

354

893

5.08

134.68

13.5

9.9

25.26

24.20

mmol/l

5.27

345

878

Congenital malformations of the circulatory system

798

3077

2.72

134.33

17.8

11.1

24.25

24.23

mmol/l

0.10

791

3030

Abnormal findings on examination of blood, without diagnosis

2577

14036

1.74

134.33

10.6

9.8

23.98

24.22

mmol/l

3.13

2526

13689

Chronic pancreatitis

820

3333

2.71

134.10

16.8

10.4

23.83

24.26

mmol/l

2.79

803

3279

Anxiety disorders

3923

17625

1.57

134.08

10.2

10.5

24.39

24.27

mmol/l

1.54

3812

17289

Abdominal and pelvic pain

4467

14908

1.54

133.68

10.7

10.0

24.28

24.21

mmol/l

0.62

4358

14560

Neurotic, stress-related and somatoform disorders

3875

17455

1.57

133.45

10.2

10.5

24.39

24.27

mmol/l

1.54

3765

17125

Psychiatric diseases

4371

14503

1.55

132.96

10.4

10.1

24.27

24.21

mmol/l

0.49

4258

14220

Other dialysis

309

712

5.56

131.63

15.4

12.9

22.55

24.32

mmol/l

14.91

300

703

Abnormalities of heart beat

1604

8191

1.97

130.74

9.4

9.6

24.26

24.12

mmol/l

0.98

1554

8051

Pleural effusion

980

4355

2.45

130.57

11.6

8.8

24.79

24.00

mmol/l

9.83

957

4235

Other functional intestinal disorders

2185

11468

1.79

130.49

8.8

9.3

24.50

24.27

mmol/l

2.48

2128

11174

Diseases of the skin and subcutaneous tissue

4363

14553

1.54

130.32

10.3

9.8

24.19

24.23

mmol/l

0.27

4248

14220

Fracture of rib(s), sternum and thoracic spine

1745

9550

1.93

129.50

11.4

9.6

24.39

24.26

mmol/l

0.87

1708

9307

Undetermined asthma

651

2369

2.93

129.36

9.0

8.2

24.59

23.74

mmol/l

9.04

628

2342

Malignant neoplasm of rectum

648

2386

3.01

129.03

8.5

10.1

23.96

24.34

mmol/l

2.52

643

2328

Dizziness and giddiness

3525

17798

1.58

128.82

8.8

10.0

24.38

24.22

mmol/l

2.07

3426

17413

Mental and behavioural disorders due to sedatives or hypnotics

447

1329

3.78

128.51

12.1

10.9

24.79

24.29

mmol/l

2.22

432

1312

Neurological diseases

3515

11234

1.61

127.10

10.5

10.6

24.27

24.06

mmol/l

3.36

3447

10973

Sequelae of cerebrovascular disease

1996

9691

1.85

126.99

10.6

8.7

24.12

24.28

mmol/l

1.30

1929

9424

Lower back pain or/and sciatica

4879

20950

1.48

126.22

8.9

10.2

24.46

24.20

mmol/l

6.41

4776

20444

Depression or dysthymia

3045

10318

1.66

125.66

9.8

10.3

24.25

24.15

mmol/l

0.83

2971

10133

Other neurological diseases

3583

18241

1.57

125.22

9.1

9.5

24.27

24.28

mmol/l

0.05

3505

17780

Disorder of lipoprotein metabolism, unspecified

791

3263

2.64

124.33

11.1

8.9

24.22

24.38

mmol/l

0.62

772

3173

Urinary track infection

2077

5769

1.85

124.25

9.3

24.26

24.38

mmol/l

0.84

2040

5664

Disorders resulting from impaired renal tubular function

336

861

4.80

123.57

16.3

11.8

22.76

24.36

mmol/l

15.30

328

853

Fungal Sepsis

348

906

4.53

123.56

19.8

8.3

24.17

24.28

mmol/l

0.17

340

885

Specific personality disorders

1017

4663

2.29

122.29

10.4

10.9

24.57

24.19

mmol/l

2.98

981

4592

Implicit fungal Sepsis

328

825

4.73

122.26

18.1

8.4

24.18

24.31

mmol/l

0.21

322

806

Dorsalgia

4332

15494

1.51

121.77

9.0

10.5

24.36

24.16

mmol/l

3.57

4237

15122

Intestinal adhesions without obstruction

573

2041

3.12

121.50

11.5

8.9

24.48

24.34

mmol/l

0.40

562

1997

Emotionally unstable personality disorder

548

1892

3.08

120.02

9.3

10.9

24.31

24.09

mmol/l

0.87

533

1872

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4452

19331

1.49

119.36

9.9

10.0

24.30

24.24

mmol/l

0.60

4339

18874

Decubitus ulcer and pressure area

495

1657

3.42

118.87

13.1

8.9

24.59

24.30

mmol/l

0.88

475

1608

External causes of morbidity and mortality

2614

7871

1.70

118.72

10.7

9.5

24.31

24.13

mmol/l

1.95

2571

7656

Factors influencing health status and contact with health services

1272

3026

2.18

118.65

11.5

9.5

24.32

24.30

mmol/l

0.08

1243

2952

Abnormalities of gait and mobility

813

3497

2.56

117.83

10.5

9.4

24.08

24.20

mmol/l

0.53

801

3414

Congenital malformations, deformations and chromosomal abnormalities

2411

13948

1.69

117.36

11.2

10.3

24.10

24.24

mmol/l

1.42

2374

13659

Cellulitis

1196

5958

2.13

117.25

11.4

10.1

24.10

24.24

mmol/l

0.68

1169

5846

Type 1 diabetes, wide definition, subgroup 1

960

4383

2.30

116.68

13.9

9.1

23.46

24.36

mmol/l

10.67

917

4299

Pacemaker

2050

11251

1.78

116.11

13.5

8.5

24.09

24.29

mmol/l

1.79

1970

10943

Fracture of lumbar spine and pelvis

1270

6478

2.08

116.03

9.6

8.6

24.43

24.31

mmol/l

0.59

1230

6286

Pain (limb, back, neck, head abdominally)

3137

9965

1.62

115.64

10.1

10.6

24.24

24.18

mmol/l

0.40

3065

9712

Sleep apnoea

4340

18844

1.49

114.90

9.9

10.1

24.67

24.18

mmol/l

19.64

4241

18456

Colon adenocarcinoma

746

3110

2.61

114.69

8.7

9.2

23.82

24.34

mmol/l

4.68

738

3015

Senile cataract

3075

11996

1.61

114.34

10.9

10.1

24.25

24.26

mmol/l

0.04

3010

11763

Cough

1771

9365

1.82

113.31

9.0

10.1

24.52

24.13

mmol/l

5.81

1730

9221

Open wound of head

2724

16290

1.62

112.34

10.4

9.9

24.31

24.22

mmol/l

0.78

2662

15895

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1259

6281

2.06

112.07

7.8

9.8

24.51

24.38

mmol/l

0.74

1239

6124

Other CVD

1213

6203

2.09

111.58

9.6

8.4

24.39

24.24

mmol/l

0.81

1162

6007

Alcohol abuse, main dg

860

3872

2.38

110.04

13.1

11.2

24.27

24.18

mmol/l

0.31

838

3805

Spondylosis

2676

13266

1.63

109.14

8.4

10.3

24.44

24.22

mmol/l

2.88

2640

12971

Genitourinary diseases

2473

7548

1.69

107.58

12.7

10.4

23.93

24.41

mmol/l

9.98

2415

7395

Mental and behavioural disorders due to opioids

257

585

5.01

107.38

13.4

11.3

25.04

24.12

mmol/l

3.77

252

573

Mycoses, including avohilmo

4096

21672

1.47

106.47

10.6

9.9

24.37

24.22

mmol/l

2.09

3989

21209

Acute alcohol intoxication

1322

7049

1.97

106.01

12.1

9.9

24.29

24.16

mmol/l

0.66

1289

6880

Dysphagia

1326

7081

1.97

105.86

10.2

9.0

24.69

24.23

mmol/l

5.31

1282

6917

Sleep disorders (combined)

4826

17852

1.44

105.47

9.5

10.0

24.47

24.15

mmol/l

9.27

4703

17441

Endocarditis

276

680

4.74

105.15

21.8

8.8

24.10

24.23

mmol/l

0.26

270

667

Allergic asthma (mode), excluding more controls

796

3401

2.36

105.13

9.1

8.3

24.58

23.77

mmol/l

10.87

772

3362

Alcoholic liver disease

662

2734

2.68

105.06

14.8

11.0

23.27

24.26

mmol/l

7.04

640

2688

Complications of internal orthopaedic prosthetic devices, implants and grafts

1205

6264

2.04

105.01

9.6

8.2

24.25

24.35

mmol/l

0.52

1181

6108

Disorders of other endocrine glands

1987

11733

1.72

104.89

10.4

9.8

24.10

24.29

mmol/l

1.65

1943

11470

Selective serotonin reuptake inhibitors

4343

15707

1.47

104.40

9.6

10.1

24.39

24.14

mmol/l

5.04

4217

15369

Other symptoms and signs involving cognitive functions and awareness

2402

13392

1.65

104.14

7.7

9.5

24.48

24.22

mmol/l

3.44

2306

13075

Fracture of shoulder and upper arm

1798

10540

1.77

103.97

10.8

9.6

24.37

24.29

mmol/l

0.45

1751

10289

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

981

4760

2.19

103.76

9.3

9.5

24.16

24.39

mmol/l

1.58

971

4636

Nonischemic cardiomyopathy

609

2423

2.75

103.53

18.1

8.9

24.21

24.34

mmol/l

0.39

596

2379

Other complications of surgical and medical care, not elsewhere classified

549

2072

2.88

103.29

12.9

9.0

24.22

24.31

mmol/l

0.26

542

2036

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2622

15320

1.60

103.18

11.3

10.2

24.12

24.26

mmol/l

1.43

2578

14993

Acute pancreatitis

1073

5395

2.11

103.00

14.4

9.6

23.81

24.24

mmol/l

3.28

1044

5265

Visual disturbances and blindness

2463

15664

1.62

102.78

9.8

9.5

24.28

24.29

mmol/l

0.05

2397

15300

Fracture of lower leg, including ankle

2529

15907

1.61

101.93

11.0

9.9

24.36

24.25

mmol/l

0.80

2480

15549

Gastroduodenal ulcer

1420

7826

1.90

101.83

11.4

8.5

23.77

24.27

mmol/l

5.43

1373

7606

Type 1 diabetes, wide definition

980

4756

2.16

101.72

13.9

9.0

23.45

24.37

mmol/l

11.33

937

4651

Other specific joint derangements/joint disorders

3103

12732

1.55

101.66

9.3

11.1

24.25

24.26

mmol/l

0.07

3045

12443

Amputation of toe

519

1949

3.01

100.98

12.6

9.8

23.76

24.16

mmol/l

1.55

503

1897

Intracranial injury

2706

16421

1.58

100.44

10.2

9.7

24.19

24.22

mmol/l

0.15

2635

16019

Visual disturbances

2277

14319

1.64

100.27

9.9

9.6

24.32

24.29

mmol/l

0.16

2222

14007

Exposure to other specified factors

3532

20799

1.49

100.27

10.6

10.3

24.32

24.23

mmol/l

0.86

3473

20349

Other/unspecified dorsalgia

1727

9978

1.77

100.18

8.5

9.9

24.43

24.24

mmol/l

1.74

1696

9742

Nontraumatic intracranial haemmorrhage

1091

5569

2.08

100.14

12.1

8.5

24.38

24.25

mmol/l

0.65

1067

5412

Other disorders of kidney and ureter

789

3588

2.39

99.81

13.1

9.8

23.46

24.28

mmol/l

10.16

773

3528

Injuries to the knee and lower leg

5180

20293

1.41

99.68

10.1

9.9

24.42

24.19

mmol/l

5.25

5073

19799

Chronic apical periodontitis

4828

19437

1.42

99.00

10.7

9.6

24.21

24.26

mmol/l

0.47

4714

18991

Traumatic subdural haemorrhage

803

3420

2.35

98.85

10.7

8.7

23.85

24.12

mmol/l

1.32

780

3328

Hypotension

1065

5439

2.10

98.61

9.6

8.3

24.43

24.23

mmol/l

1.06

1017

5255

Other bacterial intestinal infections

963

4739

2.15

97.82

12.2

9.1

23.98

24.28

mmol/l

1.90

929

4614

Non-small cell lung cancer

642

2656

2.59

97.51

7.7

8.5

24.91

24.26

mmol/l

6.86

630

2559

Used for control exclusion in common control thyroid runs

4530

16195

1.44

97.48

10.8

9.9

24.07

24.24

mmol/l

2.71

4412

15830

Unstable angina pectoris

1813

8449

1.76

97.41

9.7

8.1

24.12

24.36

mmol/l

2.23

1737

8258

Open wound of lower leg

826

3843

2.29

97.33

11.2

9.9

24.68

24.24

mmol/l

3.26

807

3761

Chronic gastritis

1411

7899

1.88

97.14

10.9

8.4

24.23

24.34

mmol/l

0.67

1367

7690

Mental and behavioural disorders due to use of other stimulants, including caffeine

194

380

5.87

96.86

13.0

24.59

24.08

mmol/l

1.17

188

371

ILD medications: azathioprine

685

2946

2.46

96.63

18.0

10.4

23.91

24.14

mmol/l

0.96

669

2900

Other bacterial intestinal infections, including avohilmo

1180

6251

1.98

96.45

11.8

9.3

23.96

24.28

mmol/l

2.58

1142

6105

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

395

1302

3.34

95.57

10.4

11.0

24.19

24.27

mmol/l

0.18

389

1280

Schizophrenia or delusion, excluding more controls

1239

6578

1.93

95.20

9.8

10.1

24.84

24.20

mmol/l

8.29

1190

6475

Injuries to the shoulder and upper arm

3912

21252

1.45

95.20

9.7

10.0

24.34

24.25

mmol/l

1.12

3829

20748

Cirrhosis of liver, NAS

415

1434

3.34

94.85

14.6

10.7

23.48

24.27

mmol/l

4.30

403

1413

Cholelithiasis, broad definition with cholecystitis

3841

17879

1.46

94.65

9.8

9.2

24.22

24.31

mmol/l

0.93

3759

17422

Myocarditis

227

512

4.82

94.39

21.2

7.5

24.26

24.20

mmol/l

0.10

221

501

Diabetic nephropathy

1053

5410

2.09

94.05

14.2

11.3

23.14

24.03

mmol/l

11.19

1020

5252

Liquid cancers, including Hilmo

1628

8389

1.78

93.53

10.2

9.8

24.21

24.39

mmol/l

1.35

1597

8132

Other dorsopathies, not elsewhere classified

4225

15506

1.44

93.22

9.3

10.5

24.32

24.16

mmol/l

2.49

4136

15135

Chronic viral hepatitis

314

915

3.83

92.99

13.2

11.8

24.37

24.22

mmol/l

0.30

309

901

Acute alcohol intoxication, ICD10

1030

5287

2.06

92.85

12.6

11.0

24.21

mmol/l

0.01

1005

5199

Finngen Rheumatological endpoints

3954

15755

1.45

92.05

9.8

10.4

24.21

24.22

mmol/l

0.06

3881

15371

Thoracic aortic aneurysm

854

4137

2.23

92.01

13.5

9.6

24.17

24.21

mmol/l

0.13

842

4053

Benign neoplasm of other and unspecified endocrine glands

741

3392

2.36

91.77

7.6

9.9

24.25

24.27

mmol/l

0.08

733

3335

Mental and behavioural disorders due to tobacco

518

2026

2.80

91.47

9.1

11.1

24.88

24.22

mmol/l

3.98

501

1998

Hernia of abdominal wall

2235

14332

1.62

91.11

11.4

9.8

24.29

24.24

mmol/l

0.32

2191

14024

Fibrosis and cirrhosis of liver

513

2012

2.84

91.02

14.2

10.2

23.48

24.34

mmol/l

6.17

501

1978

Smoking dependency

518

2034

2.79

90.75

9.1

11.2

24.88

24.25

mmol/l

3.65

501

2005

Injury, poisoning and certain other consequences of external causes

2045

6208

1.69

90.25

10.3

9.2

24.29

24.08

mmol/l

1.98

2010

6034

Suppurative and necrotic conditions of lower respiratory tract

408

1436

3.23

89.76

16.1

10.4

24.89

24.19

mmol/l

3.13

398

1408

Persons encountering health services for examination and investigation

2682

8741

1.57

88.95

10.4

10.2

24.23

24.29

mmol/l

0.38

2607

8543

Other cataract

2158

10143

1.64

88.87

10.6

9.8

24.29

24.26

mmol/l

0.15

2094

9939

Acute pancreatitis (for exclusion)

1073

5695

2.00

88.10

14.4

9.9

23.81

24.23

mmol/l

3.27

1044

5565

Disorders of choroid and retina

3803

18885

1.44

87.93

10.1

9.7

24.02

24.31

mmol/l

6.03

3692

18446

Allergic asthma (mode)

796

3663

2.19

87.80

9.1

8.7

24.58

23.77

mmol/l

10.94

772

3620

Left ventricular outflow tract obstruction (LVOTO), broad definition

572

2392

2.60

87.62

18.6

12.8

24.29

24.26

mmol/l

0.09

562

2369

Polyneuropathies and other disorders of the peripheral nervous system

1189

6541

1.92

87.50

10.5

9.6

24.20

24.22

mmol/l

0.06

1148

6394

Other viral hepatitis, including avohilmo

363

1201

3.31

87.12

13.6

12.4

24.43

24.25

mmol/l

0.46

356

1182

Nonorganic sleeping disorders, excluding more controls

826

4001

2.15

86.07

10.0

24.46

24.15

mmol/l

2.14

798

3943

Abdominal aortic aneurysm (AAA)

618

2671

2.48

85.96

12.3

7.7

24.01

24.07

mmol/l

0.17

597

2571

Oesophageal varices

324

1028

3.68

85.90

14.1

11.3

23.15

24.24

mmol/l

5.48

318

1013

Superficial injury of head

1181

6481

1.90

85.88

9.4

24.42

24.27

mmol/l

0.73

1150

6321

Vascular disorders of the intestines

450

1697

2.93

85.78

17.1

8.5

23.58

24.28

mmol/l

3.24

438

1649

Other viral hepatitis

347

1132

3.37

85.41

13.8

12.4

24.39

24.28

mmol/l

0.24

341

1116

Ascites

476

1852

2.83

85.29

15.0

9.5

23.30

24.16

mmol/l

4.61

466

1818

All influenza (not pneumonia)

676

3052

2.34

85.01

11.9

9.6

24.60

24.00

mmol/l

4.80

653

3005

Osteoporosis

1341

7042

1.83

84.91

9.5

8.3

24.75

24.40

mmol/l

2.69

1291

6871

Haemorrhage, not elsewhere classified

292

869

3.85

84.84

17.2

9.6

23.96

24.16

mmol/l

0.43

279

852

Non-small cell lung cancer, adenocarcinoma

408

1473

3.09

84.81

7.7

8.7

24.86

24.31

mmol/l

3.28

400

1433

Elevated blood glucose level

507

2040

2.72

84.51

13.2

10.5

23.90

24.26

mmol/l

1.47

494

2001

Enterocolitis due to Clostridium difficile

630

2791

2.44

84.46

12.7

9.0

23.83

24.29

mmol/l

2.31

606

2714

Azathioprine

685

3122

2.32

84.37

18.0

10.5

23.91

24.12

mmol/l

0.83

669

3072

Ventral hernia

1195

6643

1.89

84.19

11.5

9.4

24.26

24.31

mmol/l

0.21

1172

6507

Sciatica+with lumbago

2301

13294

1.57

84.15

8.1

10.5

24.45

24.22

mmol/l

3.15

2264

13022

Bipolar affective disorders

758

3593

2.20

83.85

9.8

10.6

24.48

24.21

mmol/l

1.43

732

3538

Delirium, not induced by alcohol and other psychoactive substances

779

3766

2.22

83.75

14.0

8.5

24.46

24.28

mmol/l

0.71

757

3639

Candidiasis, including avohilmo

1323

7569

1.82

83.64

11.6

9.3

24.29

24.30

mmol/l

0.03

1283

7437

Other special examinations and investigations of persons without complaint or reported diagnosis

2625

8740

1.55

82.89

10.6

10.3

24.21

24.29

mmol/l

0.62

2551

8543

Bacterial intestinal infections, IBD co-morbidities

957

4989

2.03

82.69

12.2

9.1

23.95

24.26

mmol/l

1.94

924

4859

Soft tissue disorders

4199

15492

1.41

82.69

9.9

10.4

24.14

24.22

mmol/l

0.81

4098

15108

Acute upper respiratory infections of multiple and unspecified sites

3260

16587

1.46

82.55

10.9

9.9

24.50

24.20

mmol/l

5.65

3167

16200

Other and unspecified polyneuropathies, also in other diseases

1054

5708

1.96

81.77

10.2

9.7

24.17

24.22

mmol/l

0.16

1019

5577

Gingivitis and periodontal diseases

4302

16127

1.40

81.53

10.2

9.5

24.21

24.24

mmol/l

0.27

4216

15719

Unspecified acute lower respiratory infection

788

3853

2.17

81.47

12.6

10.2

24.70

24.15

mmol/l

4.44

770

3770

Sleep apnoea, including avohilmo

4319

19072

1.40

81.43

9.7

10.1

24.66

24.17

mmol/l

19.90

4223

18666

Liquid cancers

1339

7324

1.80

81.25

10.5

9.7

24.15

24.38

mmol/l

1.67

1312

7103

Pneumothorax

438

1676

2.88

81.21

12.6

9.7

24.70

24.05

mmol/l

3.69

428

1641

Other diseases of anus and rectum

1418

8315

1.76

81.08

9.1

9.0

24.30

mmol/l

0.03

1378

8098

Other and unspecified nonorganic psychotic disorders

803

3948

2.13

80.80

10.6

11.3

24.73

24.17

mmol/l

4.45

769

3880

Idiopathic gout

607

2724

2.45

80.06

11.2

9.9

23.81

24.25

mmol/l

2.25

593

2668

Dilated cardiomyopathy

706

3363

2.28

79.93

19.8

10.1

24.04

24.16

mmol/l

0.40

685

3299

Progressive vascular leukoencephalopathy

315

1031

3.55

79.32

6.6

7.0

24.24

24.39

mmol/l

0.35

305

995

Persons with potential health hazards related to communicable diseases

1356

7832

1.76

79.22

13.5

11.0

24.27

24.09

mmol/l

1.43

1332

7691

Persistent mood disorders

862

4390

2.06

78.94

8.9

9.7

24.38

24.25

mmol/l

0.52

839

4307

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1481

8900

1.73

78.46

10.7

9.6

24.39

24.33

mmol/l

0.33

1453

8741

Malignant neoplasm of bladder, including Hilmo

668

3078

2.30

78.45

9.9

8.9

23.37

24.19

mmol/l

9.27

649

2966

Exclusions for E4_PCOS_BROAD

814

4077

2.10

78.35

10.2

11.1

24.15

24.26

mmol/l

0.50

799

4005

severe traumatic brain injury, does not include concussion

1196

6818

1.84

77.83

11.1

9.1

24.07

24.24

mmol/l

0.94

1164

6616

Cholelithiasis

3598

17596

1.42

77.78

9.8

9.2

24.21

24.31

mmol/l

1.12

3517

17150

Diagnoses used for exclusion with ILD

1267

7356

1.80

76.96

13.5

9.4

24.58

24.24

mmol/l

2.90

1236

7151

Other diseases of liver

886

4609

2.03

76.91

13.1

10.1

24.11

24.33

mmol/l

1.12

870

4526

Viral hepatitis, including avohilmo

396

1479

2.90

76.11

13.3

11.8

24.37

24.28

mmol/l

0.20

389

1457

Gastric ulcer

947

5061

1.98

76.06

11.4

8.7

23.97

24.29

mmol/l

1.83

926

4913

Other headache syndromes

1634

10083

1.66

75.98

9.0

10.0

24.45

24.23

mmol/l

2.17

1598

9876

Diseases of the eye and adnexa

3030

10460

1.48

75.83

11.0

10.8

24.11

24.21

mmol/l

0.98

2961

10255

Other gastritis (incl. Duodenitis)

1118

6295

1.86

75.59

10.9

8.9

24.10

24.31

mmol/l

1.22

1083

6147

Aortic valve malfunction, age under 60 years

521

2234

2.53

75.58

16.9

12.6

24.31

24.27

mmol/l

0.12

512

2213

Other specified and unspecified personality disorders

427

1659

2.76

75.48

11.5

10.8

24.86

24.19

mmol/l

3.55

406

1641

Malignant neoplasm of skin, including Hilmo

2218

9754

1.56

75.42

8.6

10.0

24.20

24.40

mmol/l

2.23

2166

9468

Autoimmune diseases

4660

17588

1.37

75.36

11.0

9.9

24.04

24.27

mmol/l

4.31

4532

17194

Attention to artificial openings

295

954

3.52

75.07

10.6

9.5

24.16

24.27

mmol/l

0.21

289

933

Endovascular or surgical operations to intracerebral aneurysms

370

1359

3.02

74.41

8.7

9.5

24.28

24.34

mmol/l

0.15

365

1333

Alcohol withdrawal state with delirium

437

1750

2.77

74.39

16.6

12.0

24.26

24.22

mmol/l

0.07

424

1727

Symptoms and signs involving the skin and subcutaneous tissue

3112

20878

1.44

74.29

9.4

9.8

24.31

24.26

mmol/l

0.39

3049

20395

Viral hepatitis

380

1415

2.91

73.57

13.5

11.7

24.33

24.30

mmol/l

0.06

374

1394

Fracture of skull and facial bones

1004

5508

1.90

73.48

12.4

10.3

24.20

24.22

mmol/l

0.09

971

5399

Lung diseases due to external agents

778

3953

2.10

73.00

13.6

8.8

24.63

24.20

mmol/l

2.51

753

3818

Autoimmune diseases related-to ILD

3526

21366

1.40

72.70

10.3

9.9

24.28

24.23

mmol/l

0.43

3437

20869

Other disorders of glucose regulation and pancreatic internal secretion

472

1970

2.59

72.47

15.5

10.0

24.00

24.20

mmol/l

0.46

455

1927

Panic disorder

548

2417

2.36

72.26

11.9

10.1

24.55

24.19

mmol/l

1.74

524

2378

Cerebral palsy and other paralytic syndromes

582

2657

2.34

72.22

10.0

10.4

24.44

24.25

mmol/l

0.65

572

2600

Colon adenocarcinoma, helper endpoint

746

3763

2.13

72.07

8.7

8.9

23.82

24.25

mmol/l

3.65

738

3666

Other retinal disorders

3035

16333

1.45

72.07

9.9

9.3

24.03

24.31

mmol/l

4.83

2936

15939

Malignant neoplasm of head and neck

456

1881

2.63

71.84

12.7

9.9

24.82

24.30

mmol/l

3.08

445

1832

Alcohol-induced chronic pancreatitis

398

1553

2.85

71.43

20.0

11.7

23.82

24.24

mmol/l

1.26

388

1535

Coagulation defects, purpura and other haemorrhagic conditions

930

5041

1.94

71.12

12.2

9.7

23.83

24.25

mmol/l

3.38

912

4933

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

470

1975

2.56

70.81

10.9

9.6

24.34

24.28

mmol/l

0.15

459

1938

Misadventures to patients during surgical and medical care

718

3577

2.13

70.79

14.2

9.2

24.12

24.24

mmol/l

0.41

700

3512

Non-selective monoamine reuptake inhibitors

1594

9585

1.65

70.75

9.0

9.4

24.58

24.25

mmol/l

3.65

1545

9380

Speech therapy

1237

7311

1.77

70.50

9.9

9.6

24.39

24.30

mmol/l

0.44

1215

7164

Acidosis

183

453

4.89

70.32

14.7

9.1

20.88

24.40

mmol/l

10.54

177

448

Other intervertebral disc disorders

3452

14863

1.41

69.45

9.2

10.4

24.36

24.19

mmol/l

2.36

3378

14512

Mixed and other personality disorders

373

1413

2.83

69.40

8.8

11.3

24.59

24.28

mmol/l

0.89

362

1398

Other arthrosis

2394

10903

1.51

69.16

9.1

10.7

24.24

24.33

mmol/l

0.83

2340

10652

Other diseases of arteries and capillaries

492

2138

2.48

68.97

12.8

8.9

24.04

24.25

mmol/l

0.64

478

2085

Assault

570

2616

2.29

68.89

13.3

11.7

23.86

24.21

mmol/l

1.61

560

2573

Sub-endpoint used in defining T1D endpoints

1275

7494

1.73

68.74

13.7

9.7

23.44

24.24

mmol/l

10.85

1223

7286

Other disorders of veins

1778

11337

1.59

68.68

8.7

9.3

24.69

24.33

mmol/l

4.92

1720

11104

Malignant neoplasm of head and neck, including Hilmo

520

2316

2.41

68.63

12.0

10.0

24.76

24.30

mmol/l

2.71

507

2250

Vascular diseases of the intestine

279

921

3.44

68.60

20.4

8.1

23.34

24.26

mmol/l

3.07

271

892

Other metabolic disorders

548

2484

2.32

68.23

13.3

9.0

24.36

24.37

mmol/l

0.04

540

2445

Nerve, nerve root and plexus disorders

4539

20606

1.34

68.13

9.3

10.0

24.33

24.24

mmol/l

1.24

4436

20110

General examination and investigation of persons without complaint and reported diagnosis

2477

8716

1.50

68.13

10.3

24.20

24.29

mmol/l

0.59

2409

8524

Transport accidents

1787

9581

1.59

68.10

10.7

9.9

24.35

24.15

mmol/l

1.84

1756

9359

Recurrent or chronic depression

1492

6340

1.67

68.04

10.0

11.0

24.22

24.21

mmol/l

0.02

1458

6255

Malignant neoplasm of bladder

419

1707

2.67

67.93

11.2

8.2

23.38

24.25

mmol/l

6.33

405

1636

Cholecystectomy

3045

18576

1.42

67.40

10.0

9.2

24.22

24.31

mmol/l

0.89

2988

18101

Fall on and from stairs and steps

1209

7187

1.75

67.10

10.7

9.7

24.46

24.28

mmol/l

1.13

1177

7042

Arterial embolism and thrombosis

360

1375

2.88

66.95

13.2

8.0

23.76

24.18

mmol/l

1.35

345

1334

Special screening examination for infectious and parasitic diseases

857

3282

1.95

66.50

10.8

11.2

24.17

24.21

mmol/l

0.12

829

3242

Malignant neoplasm of oral cavity, including Hilmo

282

953

3.32

66.21

13.1

10.1

24.90

24.30

mmol/l

2.97

275

933

Diseases of pulp and periapical tissues, including avohilmo

4310

16758

1.35

65.20

10.2

9.7

24.18

24.26

mmol/l

0.73

4203

16341

Pneumonia due to other infectious organisms, not elsewhere classified

215

621

3.92

65.16

11.1

9.4

24.46

23.90

mmol/l

2.03

210

609

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

377

1494

2.75

64.92

14.7

9.1

23.80

24.30

mmol/l

2.27

371

1445

Other and unspecified mood [affective] disorders

309

1097

2.99

64.64

10.5

10.0

23.98

24.22

mmol/l

0.60

299

1083

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

367

1439

2.78

64.57

10.2

10.1

24.42

24.33

mmol/l

0.19

361

1406

Diabetic maculopathy, excluding more controls

536

2477

2.30

64.43

13.5

8.3

23.30

24.45

mmol/l

10.26

520

2416

Malignant neoplasm of skin

2079

9431

1.53

64.41

8.5

10.0

24.20

24.40

mmol/l

2.01

2031

9155

Soft tissue disorders related to use, overuse and pressure

1281

7818

1.70

64.21

9.8

10.0

24.46

24.33

mmol/l

0.81

1252

7663

Polyuria

1107

6522

1.78

64.02

8.7

9.6

24.31

24.21

mmol/l

0.48

1076

6369

Overexertion and strenuous or repetitive movements

499

2254

2.37

63.66

11.9

10.8

24.26

24.29

mmol/l

0.06

489

2215

Dorsopathies

4106

15568

1.36

63.44

9.7

10.6

24.23

24.16

mmol/l

0.71

4013

15196

Chronic ulcer of skin, not elsewhere classified

421

1786

2.58

63.01

10.2

9.5

24.62

24.25

mmol/l

1.18

408

1744

Benign neoplasm of other and ill-defined parts of digestive system

880

4886

1.90

62.84

10.1

9.2

24.41

24.33

mmol/l

0.33

860

4790

Injuries to unspecified part of trunk, limb or body region

539

2535

2.27

62.30

12.3

9.9

24.43

24.23

mmol/l

0.73

529

2487

Bronchiectasis

429

1850

2.51

61.55

8.6

9.0

25.19

24.03

mmol/l

9.25

408

1818

Disturbances of skin sensation

1103

6537

1.74

61.42

8.5

10.3

24.39

24.24

mmol/l

0.95

1084

6430

Other embolism and thrombosis

643

3246

2.10

61.29

12.1

9.8

24.16

24.29

mmol/l

0.43

629

3182

Other and unspecified effects of external causes

1085

6405

1.75

61.23

11.4

10.5

24.14

24.19

mmol/l

0.20

1070

6282

Acute peritonitis

385

1598

2.64

60.54

16.0

10.8

23.25

24.23

mmol/l

6.18

378

1562

Transient ischemic attack

2402

13451

1.46

60.26

8.7

9.1

24.19

24.30

mmol/l

0.92

2341

13102

Gastro-oesophageal reflux disease

2859

17462

1.41

60.19

10.2

9.6

24.41

24.30

mmol/l

1.07

2787

17081

Osteomyelitis

393

1655

2.60

59.90

12.0

10.6

24.02

24.17

mmol/l

0.31

385

1624

Glucagon-like peptide-1 (GLP-1) analogues

1341

8421

1.65

59.86

11.1

10.3

24.29

24.36

mmol/l

0.30

1309

8301

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1341

8421

1.65

59.86

11.1

10.3

24.29

24.36

mmol/l

0.30

1309

8301

Status post-ami

1225

5659

1.71

59.59

8.9

8.0

23.86

24.29

mmol/l

3.68

1171

5531

KRA_PSY_EATING, excluding more controls

243

775

3.23

59.53

10.8

10.1

24.30

23.80

mmol/l

1.32

232

770

Pneumonitis due to solids and liquids

484

2228

2.34

59.46

16.3

9.1

24.69

24.16

mmol/l

2.27

469

2155

Pyothorax

297

1102

3.04

59.36

15.4

10.3

24.93

24.22

mmol/l

2.64

291

1082

Hypoglycaemia, other or unspecified

378

1569

2.61

58.94

16.4

10.4

23.80

24.23

mmol/l

1.24

364

1536

Other pleural conditions

567

2792

2.18

58.44

11.0

8.8

24.84

23.99

mmol/l

6.27

543

2709

Malignant neoplasm of oral cavity

231

751

3.49

58.32

13.4

9.3

24.88

24.29

mmol/l

2.51

226

736

Iron deficiency anaemia secondary to blood loss (chronic)

784

4308

1.91

57.69

12.7

8.4

23.89

24.33

mmol/l

2.84

762

4196

Lumbar disc prolapse

2664

14178

1.42

57.60

9.9

10.6

24.34

24.21

mmol/l

1.32

2619

13877

Systemic connective tissue disorders

1496

9719

1.59

57.55

9.8

8.8

24.43

24.33

mmol/l

0.60

1458

9497

Malignant neoplasm of breast, HER2-negative, including Hilmo

1335

5298

1.65

57.44

7.2

9.0

24.57

24.63

mmol/l

0.25

1308

5163

Malignant neoplasm of breast, including Hilmo

1335

5298

1.65

57.41

7.2

9.0

24.57

24.63

mmol/l

0.25

1308

5163

Diseases of the myoneural junction and muscle

640

3309

2.06

57.28

10.4

9.8

24.67

24.23

mmol/l

2.03

620

3234

Other and unspecified drugs and medicaments

444

2003

2.38

57.09

11.0

9.8

24.35

24.25

mmol/l

0.23

434

1964

Other disorders of the musculoskeletal system and connective tissue

725

3907

1.96

57.02

9.7

9.6

24.33

24.28

mmol/l

0.18

713

3836

Hypertensive Renal Disease

226

731

3.42

56.91

10.6

7.9

23.56

24.26

mmol/l

2.03

217

704

Schizophrenia or delusion

1239

7715

1.65

56.88

9.8

10.8

24.84

24.18

mmol/l

8.87

1190

7571

Mycoses

1243

7766

1.66

56.78

12.2

9.8

24.21

24.24

mmol/l

0.10

1215

7607

Coxarthrosis [arthrosis of hip](FG)

2502

12261

1.44

56.74

8.4

9.9

24.34

24.28

mmol/l

0.35

2445

11950

Use of disulfiram, acamprosate or naltrexone

444

2010

2.37

56.55

12.9

12.1

24.14

24.28

mmol/l

0.34

430

1984

Coxarthrosis

2289

10340

1.46

56.51

8.4

10.4

24.30

24.32

mmol/l

0.11

2234

10077

Diseases of peritoneum

521

2517

2.21

56.33

13.6

9.8

23.46

24.30

mmol/l

6.29

509

2459

Malignant neoplasm of breast, HER2-negative

1313

5255

1.65

56.22

7.4

9.0

24.58

24.63

mmol/l

0.18

1284

5120

Insulin, fast-acting (human)

577

2878

2.10

56.12

15.0

9.7

23.29

24.34

mmol/l

9.21

554

2819

Subarachnoid haemorrhage

530

2581

2.19

56.03

12.7

8.8

24.31

24.29

mmol/l

0.05

523

2520

Benign neoplasm: Colon, unspecified

1253

7896

1.66

55.95

9.0

9.4

24.13

24.27

mmol/l

0.89

1209

7735

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1960

9017

1.50

55.90

8.4

10.0

24.22

24.40

mmol/l

1.55

1910

8752

Asthma and opportunity respiratory infection

288

1083

2.97

55.85

8.9

8.7

25.35

24.12

mmol/l

8.44

277

1063

Other diseases of blood and blood-forming organs, wide

1004

5978

1.75

55.78

12.3

9.9

24.29

24.28

mmol/l

0.01

985

5866

Malignant neoplasm of breast

1312

5260

1.65

55.74

7.4

9.0

24.59

24.63

mmol/l

0.17

1283

5125

Sequelae of injuries, of poisoning and of other consequences of external causes

1023

6116

1.74

55.62

12.6

10.5

24.29

24.25

mmol/l

0.17

999

6015

Diabetic retinopathy, excluding more controls

1274

4410

1.69

55.37

13.5

12.1

23.60

24.16

mmol/l

6.03

1241

4313

Superficial injury of lower leg

1078

6532

1.70

55.28

9.2

9.8

24.52

24.23

mmol/l

2.40

1059

6401

Schizophrenia, schizotypal and delusional disorders

1236

7755

1.64

54.99

9.9

10.7

24.84

24.19

mmol/l

9.00

1189

7609

Asthma and allergy, excluding more controls

391

1651

2.41

54.96

8.7

8.0

24.58

23.69

mmol/l

7.25

378

1622

Unspecified mental disorder

1544

10185

1.55

54.80

10.2

10.6

24.75

24.18

mmol/l

8.61

1494

9994

L04AX Other immunosuppressants

2278

16200

1.44

54.69

12.6

9.9

24.34

24.28

mmol/l

0.33

2226

15895

188

565

3.92

54.68

6.9

9.6

25.39

24.12

mmol/l

5.29

179

555

Postprocedural endocrine and metabolic disorders, not elsewhere classified

480

2256

2.23

54.66

12.4

9.1

24.31

24.35

mmol/l

0.10

472

2221

Other and unspecified local infections of skin and subcutaneous tissue

495

2375

2.22

54.33

13.5

10.1

24.04

24.24

mmol/l

0.75

477

2334

In situ neoplasms

1735

11771

1.52

54.32

8.8

8.6

24.15

24.29

mmol/l

1.13

1708

11456

Fentanyl

489

2328

2.21

53.96

11.6

8.6

25.23

24.20

mmol/l

8.26

476

2245

Hydronephrosis

548

2734

2.12

53.90

9.5

8.5

23.19

24.52

mmol/l

13.83

536

2674

Exclusions for E4_PCOS_CONSORTIUM

2503

11166

1.42

53.87

9.2

9.8

24.40

24.34

mmol/l

0.49

2451

10920

Non-small cell lung cancer, adenocarcinoma, helper endpoint

408

1836

2.44

53.75

7.7

9.0

24.86

24.19

mmol/l

5.24

400

1797

Other local infections of skin and subcutaneous tissue

521

2562

2.16

53.54

13.3

10.1

24.06

24.24

mmol/l

0.66

501

2516

Generalized anxiety disorder

542

2673

2.09

53.53

9.1

10.1

24.09

24.15

mmol/l

0.18

527

2635

Benign neoplasm: Sigmoid colon

946

5623

1.77

53.42

10.1

9.8

24.14

24.27

mmol/l

0.58

926

5513

Deforming dorsopathies

1146

7116

1.66

53.25

8.3

9.9

24.48

24.26

mmol/l

1.51

1130

6990

Disorders of eyelid, lacrimal system and orbit

3645

20399

1.33

52.79

8.6

10.0

24.49

24.22

mmol/l

6.05

3547

19929

Second line medication for Crohn's disease

2319

16638

1.42

52.70

12.5

10.0

24.33

24.28

mmol/l

0.29

2267

16323

Disorders of parathyroid gland

947

5575

1.75

52.43

9.8

8.3

24.12

24.46

mmol/l

2.33

925

5440

Missing teeth due to accident, extraction or parodontitis

2790

18433

1.38

52.42

9.7

24.39

24.28

mmol/l

1.00

2728

18052

Subjective visual disturbances

1089

6717

1.68

52.40

9.3

9.5

24.42

24.34

mmol/l

0.39

1061

6596

Phlebitis and thrombophlebitis (not including DVT)

1006

6093

1.72

52.23

9.8

9.7

24.27

24.25

mmol/l

0.09

987

5972

Disorders of mineral metabolism

411

1870

2.34

51.52

10.9

9.2

23.82

24.35

mmol/l

2.02

400

1833

Other noninfective gastroenteritis and colitis

1052

6454

1.68

51.48

10.6

9.7

24.07

24.26

mmol/l

1.08

1025

6308

Symptoms and signs concerning food and fluid intake

495

2412

2.16

51.41

10.5

9.5

24.37

24.17

mmol/l

0.50

478

2374

Acute upper respiratory infections

4292

20059

1.30

51.22

10.3

9.6

24.46

24.21

mmol/l

5.73

4175

19586

Abnormal serum enzyme levels

1525

9874

1.55

50.98

10.0

10.3

23.95

24.17

mmol/l

2.14

1507

9632

Diseases of the musculoskeletal system and connective tissue

1984

6845

1.48

50.25

10.5

11.3

24.23

24.15

mmol/l

0.53

1944

6674

Injury of other and unspecified intrathoracic organs

361

1581

2.48

50.18

15.7

10.6

24.28

24.26

mmol/l

0.05

353

1553

Other systemic involvement of connective tissue (FG)

1061

6444

1.67

50.07

9.1

24.48

24.34

mmol/l

0.75

1036

6285

Injuries to the ankle and foot

2774

17582

1.37

49.93

10.5

10.7

24.30

24.23

mmol/l

0.53

2719

17235

Basal cell carcinoma, including Hilmo

1876

8785

1.48

49.84

8.4

9.7

24.22

24.40

mmol/l

1.71

1829

8525

Myalgia

941

5663

1.71

49.52

10.7

9.8

24.42

24.29

mmol/l

0.62

929

5556

Adenocarcinoma and Papillary adenocarcinoma of kidney

116

269

5.54

49.44

9.1

10.1

23.03

24.38

mmol/l

5.53

116

263

Glomerulonephritis

491

2439

2.15

49.34

13.2

10.8

23.49

24.23

mmol/l

4.96

483

2394

Symptoms and signs involving speech and voice

1423

9467

1.55

49.18

9.9

9.3

24.50

24.27

mmol/l

2.12

1395

9267

Toxic effects of substances chiefly nonmedicinal as to source

509

2556

2.10

49.08

10.5

10.6

24.12

24.25

mmol/l

0.38

496

2514

Dental caries, including avohilmo

3101

11877

1.36

48.84

9.8

9.4

24.29

24.24

mmol/l

0.33

3014

11568

Intracerebral haemorrhage

648

3548

1.92

48.52

12.3

8.5

24.43

24.24

mmol/l

0.75

629

3426

Nonorganic sleeping disorders

826

4830

1.77

48.45

10.0

10.5

24.46

24.20

mmol/l

1.63

798

4742

Asthma and allergy

390

1738

2.28

48.34

8.6

24.58

23.71

mmol/l

6.97

377

1708

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1854

8747

1.47

47.98

8.4

9.8

24.16

24.40

mmol/l

2.50

1806

8487

Mental disorders, not otherwise specified

339

1462

2.45

47.85

11.7

11.0

24.45

24.19

mmol/l

0.79

331

1445

Other viral diseases

1067

6658

1.64

47.75

13.5

11.1

24.22

24.15

mmol/l

0.31

1044

6528

Osteonecrosis

348

1540

2.45

47.34

11.2

10.3

24.47

24.35

mmol/l

0.26

340

1517

Hepatic failure, not elsewhere classified

239

895

2.99

46.88

24.0

11.0

22.99

24.31

mmol/l

5.19

233

876

Alcohol-induced acute pancreatitis

234

868

3.03

46.84

19.8

12.3

23.59

24.29

mmol/l

1.85

229

861

Diseases of pulp and periapical tissues and dental caries

2787

10593

1.37

46.71

9.4

9.3

24.23

24.26

mmol/l

0.13

2710

10306

Dermatophytosis, including avohilmo

2691

19757

1.36

46.58

10.1

10.0

24.40

24.23

mmol/l

1.83

2626

19348

Memory loss

493

2514

2.10

46.47

6.9

8.7

24.67

24.30

mmol/l

1.56

465

2457

Nonalcoholic fatty liver disease

465

2310

2.13

46.43

13.5

11.0

24.15

24.32

mmol/l

0.48

459

2277

Phobic anxiety disorders

428

2039

2.16

46.35

11.4

10.9

24.36

24.10

mmol/l

0.89

419

2012

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

281

1143

2.68

46.09

16.1

9.0

23.77

24.18

mmol/l

1.40

276

1106

Certain disorders involving the immune mechanism

816

4840

1.76

46.05

14.6

10.4

24.23

24.28

mmol/l

0.16

797

4759

Benign neoplasm: Rectum, anus and anal canal

965

5990

1.68

46.00

9.0

9.6

24.28

24.30

mmol/l

0.06

933

5860

Familial hypercholesterolemia

680

3840

1.85

45.79

9.4

8.6

23.96

24.35

mmol/l

2.21

663

3739

Injuries to the elbow and forearm

2811

18161

1.35

45.73

10.0

9.9

24.31

24.29

mmol/l

0.13

2748

17757

Caries of dentine, including avohilmo

3275

12746

1.33

45.67

9.6

9.5

24.28

24.25

mmol/l

0.21

3193

12414

Persons encountering health services in other circumstances

1498

10086

1.50

45.54

9.5

9.4

24.50

24.24

mmol/l

2.34

1465

9858

Left bundle-branch block

339

1499

2.40

45.45

9.4

8.1

23.76

24.22

mmol/l

1.49

332

1474

Umbilical hernia

1198

7822

1.58

45.39

11.5

10.5

24.33

24.19

mmol/l

0.75

1177

7666

Protozoal diseases

198

684

3.29

45.35

12.5

11.3

24.26

24.36

mmol/l

0.17

193

673

Benign neoplasm: Rectum

876

5334

1.72

45.23

9.2

9.7

24.30

24.28

mmol/l

0.08

846

5225

Covid-19 suspected case

773

4524

1.76

45.13

10.3

9.6

24.35

24.17

mmol/l

0.81

755

4437

Protozoal diseases, including avohilmo

202

708

3.23

45.01

12.3

11.1

24.25

24.36

mmol/l

0.21

197

697

Enlarged lymph nodes

620

3411

1.88

44.93

11.7

10.1

24.26

24.19

mmol/l

0.20

613

3348

Abnormal spermatozoa

134

4172

0.30

44.87

6.3

10.7

24.30

24.11

mmol/l

0.35

134

4085

Symptoms and signs involving the nervous and musculoskeletal systems

2418

17960

1.37

44.70

9.6

24.32

24.26

mmol/l

0.45

2369

17530

Injury of unspecified body region

393

1866

2.25

44.60

12.4

10.2

24.39

24.22

mmol/l

0.46

383

1829

Open wound of ankle and foot

482

2459

2.07

44.59

11.2

10.6

24.11

24.22

mmol/l

0.29

477

2414

Viral and other specified intestinal infections, including avohilmo

935

5533

1.66

44.53

11.6

10.2

23.98

24.16

mmol/l

0.92

912

5416

Post-traumatic stress disorder

272

1094

2.58

44.21

11.4

10.5

23.84

24.03

mmol/l

0.43

264

1082

Neuromuscular dysfunction of bladder

439

2179

2.14

44.09

10.4

9.8

24.41

24.24

mmol/l

0.47

430

2147

Disorders of calcium metabolism

316

1378

2.46

44.03

9.9

8.3

23.59

24.41

mmol/l

3.21

308

1346

Other and unspecified coagulation defects

251

989

2.74

43.69

13.3

10.1

24.01

24.27

mmol/l

0.66

246

970

Diseases of oral cavity, salivary glands and jaws

2429

9177

1.39

43.66

9.3

24.22

24.24

mmol/l

0.12

2354

8928

Other symptoms and signs involving the urinary system

513

2707

2.00

43.25

8.0

10.2

24.27

24.24

mmol/l

0.06

504

2649

Abscess of anal and rectal regions

380

1795

2.23

43.22

11.1

10.8

23.85

24.25

mmol/l

1.47

368

1757

Shoulder lesions

3074

14070

1.33

43.20

8.5

10.2

24.33

24.27

mmol/l

0.53

3013

13743

Pneumonia derived septicemia

203

726

3.09

43.14

14.4

10.3

24.10

24.09

mmol/l

0.01

197

712

Adverse effects, not elsewhere classified

742

4360

1.76

42.91

11.4

10.2

24.30

24.22

mmol/l

0.27

732

4283

Cholecystitis

667

3819

1.83

42.90

9.2

8.8

24.31

24.28

mmol/l

0.09

653

3698

Hyperkinetic disorders, excluding more controls

303

1199

2.42

42.84

12.7

11.6

24.02

23.85

mmol/l

0.45

294

1187

Basal cell carcinoma

1778

8550

1.45

42.63

8.3

9.6

24.20

24.42

mmol/l

2.11

1733

8296

Speech and linguistic disorders, excluding more controls

274

1052

2.54

42.43

13.6

11.5

24.19

24.10

mmol/l

0.19

268

1036

Myocardial infarction, with ST-elevation

865

5342

1.69

42.17

10.5

9.2

23.62

24.22

mmol/l

6.33

841

5166

Other and unspecified injuries of head

374

1780

2.24

42.09

10.6

9.5

24.29

24.33

mmol/l

0.06

366

1736

Migraine with aura

758

4495

1.72

41.74

8.8

9.8

24.30

24.14

mmol/l

0.88

741

4413

Other arthritis (FG)

1251

8379

1.53

41.72

11.0

10.2

24.15

24.27

mmol/l

0.71

1228

8203

Benign neoplasm: Ascending colon

703

4140

1.79

41.42

8.6

9.5

24.21

24.29

mmol/l

0.25

675

4066

Other coagulation defects

347

1616

2.28

41.19

13.0

10.0

24.01

24.21

mmol/l

0.51

338

1583

Hyperparathyroidism

809

4883

1.70

40.95

9.8

8.3

23.96

24.44

mmol/l

3.69

788

4759

Gonarthrosis [arthrosis of knee](FG)

3094

13708

1.32

40.80

8.1

10.2

24.31

24.28

mmol/l

0.20

3021

13377

Other diseases of pancreas

434

2213

2.09

40.79

16.8

9.8

23.81

24.24

mmol/l

1.92

425

2172

Other viral diseases, including avohilmo

1304

8741

1.51

40.75

13.3

11.0

24.21

24.16

mmol/l

0.25

1276

8582

Other orthopaedic follow-up care

277

1183

2.51

40.50

9.1

9.6

24.56

24.35

mmol/l

0.49

271

1162

Paracetamol or NSAID medication

592

1599

1.91

39.99

11.2

12.6

24.23

24.05

mmol/l

0.64

578

1548

Assault by bodily force

310

1390

2.34

39.97

12.2

11.7

23.87

24.25

mmol/l

1.18

304

1371

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3608

22230

1.28

39.96

9.8

10.2

24.29

24.24

mmol/l

0.46

3521

21736

Abnormal involuntary movements

608

3471

1.83

39.57

8.0

10.1

24.34

24.26

mmol/l

0.25

583

3403

Ptosis of eyelid

552

3072

1.90

39.54

8.9

9.6

24.60

24.26

mmol/l

1.70

534

3020

Viral and other specified intestinal infections

689

3944

1.75

39.53

12.2

10.3

23.90

24.18

mmol/l

1.35

672

3853

Abnormal findings on diagnostic imaging of other body structures

628

3618

1.81

39.52

9.5

9.3

24.12

24.23

mmol/l

0.36

614

3553

Other disorders of skin and subcutaneous tissue, not elsewhere classified

634

3663

1.81

39.50

9.4

9.3

24.53

24.27

mmol/l

1.02

609

3586

Open wound of forearm

444

2311

2.02

38.83

9.6

10.1

24.59

24.22

mmol/l

1.82

431

2259

Other diseases of stomach and duodenum

331

1555

2.28

38.74

11.0

9.3

23.91

24.34

mmol/l

1.43

324

1524

Other diseases of hard tissues of teeth

2352

9072

1.37

38.50

9.4

24.25

mmol/l

0.01

2287

8848

Other specified/unspecified arthritis

1084

7181

1.55

38.19

10.9

10.5

24.20

24.31

mmol/l

0.58

1063

7026

Noninfective enteritis and colitis

1804

13109

1.40

38.11

10.9

10.1

24.02

24.26

mmol/l

2.41

1751

12813

Arthropathies

3339

13182

1.30

38.09

9.7

11.0

24.10

24.25

mmol/l

1.80

3274

12856

Amputation of thigh

199

757

2.93

37.94

15.3

7.9

24.27

24.24

mmol/l

0.04

192

729

Disorders of continuity of bone

423

2181

2.03

37.90

9.9

10.4

24.41

24.33

mmol/l

0.19

417

2152

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

270

1178

2.47

37.86

13.7

8.9

23.67

24.21

mmol/l

2.05

264

1141

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

678

4037

1.75

37.82

11.2

10.1

24.19

24.28

mmol/l

0.29

667

3967

Other arterial embolism and thrombosis

173

612

3.15

37.69

15.3

7.8

24.09

24.38

mmol/l

0.48

165

594

Carcinoma in situ of colon

196

748

2.97

37.54

11.9

10.4

23.91

24.34

mmol/l

1.23

196

741

Other or ill-defined heart diseases

236

967

2.59

37.50

16.6

8.5

24.32

24.13

mmol/l

0.40

226

948

Kela-code for severe mental illness

1330

9203

1.48

37.50

9.6

10.6

24.80

24.18

mmol/l

8.43

1283

9027

Other disorders of eye and adnexa

576

3287

1.82

37.29

10.2

10.0

24.26

24.27

mmol/l

0.04

557

3233

Candidiasis

585

3356

1.81

37.23

16.1

9.8

23.99

24.28

mmol/l

1.11

567

3298

Arterial embolism and thrombosis of lower extremity artery

207

810

2.81

37.01

11.8

7.9

23.60

24.30

mmol/l

2.25

200

787

Diplopia

586

3378

1.81

36.94

10.5

9.6

24.48

24.27

mmol/l

0.79

572

3316

Arthrosis

2806

11830

1.32

36.83

9.0

10.6

24.21

24.31

mmol/l

0.94

2737

11534

Malignant neoplasm of mesothelium and soft tissue

221

895

2.70

36.76

11.0

10.2

24.51

24.27

mmol/l

0.55

216

877

Other joint disorders

3221

13143

1.29

36.55

8.9

10.9

24.11

24.25

mmol/l

1.68

3153

12819

Seropositive rheumatoid arthritis

981

6400

1.57

36.25

9.1

9.4

24.54

24.38

mmol/l

0.74

959

6247

Focal brain injury

305

1420

2.27

36.16

12.5

9.9

24.38

24.09

mmol/l

0.75

295

1386

Other and unspecified myopathies

444

2376

1.98

36.16

11.2

9.7

24.69

24.27

mmol/l

1.26

428

2322

Pneumococcal septicemia

195

756

2.85

35.66

14.4

10.7

24.06

24.31

mmol/l

0.39

189

743

DVT of lower extremities

823

5222

1.63

35.65

8.8

9.5

24.26

mmol/l

0.00

804

5106

Other viral diseases, not elsewhere classified

694

4198

1.70

35.64

14.2

10.9

24.50

24.21

mmol/l

1.58

678

4128

Arthropathies in other diseases classified elsewhere

199

782

2.78

35.24

11.6

12.0

24.22

24.25

mmol/l

0.04

193

768

Eating disorder

246

1053

2.41

34.79

10.8

24.32

23.86

mmol/l

1.22

235

1035

Rheumatoid arthritis

1257

7711

1.48

34.73

8.9

9.9

24.51

24.37

mmol/l

0.81

1231

7523

Gonarthrosis

2591

11251

1.32

34.64

7.8

10.5

24.26

24.33

mmol/l

0.49

2529

10970

Tubulo-interstitial nephritis, not specified as acute or chronic

300

1412

2.24

34.61

10.1

7.9

24.25

24.60

mmol/l

0.86

286

1371

Fracture of foot, except ankle

916

5977

1.57

34.60

10.4

10.6

24.42

24.23

mmol/l

1.03

894

5872

Duodenal ulcer

533

3052

1.83

34.59

12.0

8.9

23.58

24.24

mmol/l

3.43

505

2955

Congenital malformations of pulmonary and tricuspid valves

7.44

34.52

28.1

16.8

24.36

24.29

mmol/l

0.06

Other disorders of adrenal gland

224

938

2.57

34.46

13.3

10.8

23.87

24.25

mmol/l

1.00

218

921

Biomechanical lesions, not elsewhere classified

265

1197

2.39

34.43

8.2

9.9

24.10

24.32

mmol/l

0.62

260

1176

Stomatitis and related lesions

779

4915

1.64

34.32

11.4

9.9

24.29

24.25

mmol/l

0.10

763

4833

Other specified and unspecified disorders of eye and adnexa

199

792

2.74

34.28

12.1

9.4

24.13

24.27

mmol/l

0.26

191

773

Noninfectious colitis NAS

566

3301

1.78

34.04

10.3

9.7

24.18

24.32

mmol/l

0.42

557

3232

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

743

4651

1.66

34.04

11.0

10.1

24.21

24.26

mmol/l

0.15

732

4570

Exposure to other and unspecified inanimate mechanical forces

341

1702

2.11

33.74

14.1

11.2

24.55

24.27

mmol/l

0.97

336

1678

Vitreous haemorrhage

485

2725

1.87

33.70

12.9

9.8

23.68

24.20

mmol/l

2.86

471

2670

Dermatitis

2502

19006

1.31

33.57

10.2

9.8

24.17

24.27

mmol/l

0.79

2428

18592

Rotator cuff syndrome

2518

13400

1.31

33.49

8.8

10.2

24.32

24.28

mmol/l

0.24

2473

13100

Complex cardiac defects

7.87

33.39

46.8

11.8

24.08

24.19

mmol/l

0.09

Superficial injury of hip and thigh

649

3947

1.70

33.30

8.3

8.9

24.59

24.26

mmol/l

1.56

631

3837

Behavioural syndromes associated with physiological disturbances and physical factors

3604

19672

1.25

33.16

9.4

10.3

24.33

24.26

mmol/l

0.66

3516

19263

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

545

2726

1.78

33.10

14.2

11.8

24.02

23.91

mmol/l

0.37

531

2671

Other systemic involvement of connective tissue

1087

7428

1.50

33.09

9.1

8.8

24.47

24.33

mmol/l

0.75

1062

7269

Viral infections characterized by skin and mucous membrane lesions

1652

12125

1.39

33.07

10.9

10.2

24.24

24.26

mmol/l

0.08

1606

11881

Diabetic neuropathy

623

3774

1.74

33.04

11.9

12.1

23.81

23.91

mmol/l

0.27

600

3668

Purpura and other haemorrhagic conditions

584

3477

1.75

32.75

11.3

9.9

23.75

24.24

mmol/l

2.95

574

3409

Trochanteric bursitis

599

3585

1.73

32.74

8.4

8.8

24.55

24.39

mmol/l

0.68

582

3518

Personal history of other diseases and conditions

339

1689

2.06

32.55

13.3

8.8

24.07

24.18

mmol/l

0.25

333

1667

Chronic rhinitis, nasopharyngitis and pharyngitis

1222

8566

1.46

32.21

10.2

10.1

24.41

24.22

mmol/l

1.35

1199

8409

Follow-up examination after treatment for malignant neoplasms

460

2574

1.87

32.12

8.4

8.8

23.90

24.36

mmol/l

2.35

452

2525

Reimbursement for rheumatic diseases

2156

16475

1.32

31.40

10.7

9.6

24.45

24.31

mmol/l

1.22

2111

16112

Migraine

1532

8654

1.40

31.36

9.2

10.4

24.28

24.19

mmol/l

0.57

1500

8483

malignant neoplasm of male genital organs, including Hilmo

1277

5383

1.46

31.29

8.5

11.5

23.83

24.18

mmol/l

3.42

1253

5228

Sequelae of injuries of lower limb

388

2080

1.95

31.11

12.1

10.3

24.22

24.32

mmol/l

0.25

377

2046

Zoster [herpes zoster], including avohilmo

2129

15797

1.32

31.07

9.0

9.3

24.33

24.31

mmol/l

0.09

2080

15443

Volvulus

160

608

2.89

30.43

12.3

9.2

24.31

24.27

mmol/l

0.05

155

593

Other viral diseases, not elsewhere classified, including avohilmo

909

6045

1.53

30.37

13.9

10.8

24.39

24.16

mmol/l

1.49

889

5932

Dementia in Alzheimer disease

327

5138

0.52

30.30

4.6

7.2

24.08

24.28

mmol/l

0.41

302

4945

Superficial injury of thorax

629

3892

1.67

30.26

10.7

9.6

24.16

24.26

mmol/l

0.34

615

3804

Inflammatory diseases of the central nervous system

361

1914

1.98

30.07

12.0

10.6

24.42

24.29

mmol/l

0.32

354

1880

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

802

5173

1.56

29.95

13.1

10.3

24.01

24.13

mmol/l

0.45

782

5082

Dermatitis and eczema

4406

21666

1.22

29.86

10.2

10.0

24.28

24.24

mmol/l

0.39

4286

21172

Other eating disorders

155

576

2.81

29.77

10.9

10.1

24.20

23.84

mmol/l

0.57

149

565

Acute posthaemorrhagic anaemia

193

812

2.58

29.65

10.2

8.7

23.61

24.42

mmol/l

2.12

182

787

Malignant neoplasm of breast, HER-positive

969

4871

1.51

29.64

6.8

8.5

24.63

24.64

mmol/l

0.04

946

4750

Other and unspecified dermatitis

2051

15797

1.32

29.60

10.2

9.7

24.22

24.29

mmol/l

0.43

1993

15465

Type 1 diabetes, definitions combined

300

1486

2.08

29.56

15.5

10.4

22.75

24.31

mmol/l

8.18

288

1470

Adrenocortical insufficiency

184

758

2.63

29.52

13.4

10.5

23.95

24.23

mmol/l

0.55

178

742

Malignant neoplasm of breast, ER-positive, including Hilmo

970

4876

1.51

29.49

6.8

8.5

24.63

24.64

mmol/l

0.03

947

4755

Other diseases of lip and oral mucosa

1610

12004

1.37

29.39

10.2

9.7

24.41

24.32

mmol/l

0.61

1573

11772

Olecranon bursitis

315

1614

2.08

29.36

12.8

12.0

24.49

24.17

mmol/l

1.01

309

1588

Conjunctivitis

2713

17365

1.27

29.16

9.6

10.2

24.40

24.28

mmol/l

1.26

2647

17016

Malignant melanoma

614

3814

1.67

29.12

8.4

9.5

24.34

mmol/l

0.01

603

3705

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1820

13222

1.34

28.90

9.5

10.0

24.39

24.31

mmol/l

0.54

1769

12970

Acute sinusitis

1829

12620

1.34

28.77

9.6

10.2

24.34

24.21

mmol/l

1.08

1787

12370

Superficial injury of abdomen, lower back and pelvis

601

3720

1.67

28.74

10.4

9.7

24.47

24.18

mmol/l

1.23

583

3642

Benign neoplasm: Caecum

514

3081

1.75

28.61

10.4

9.4

24.15

24.27

mmol/l

0.38

500

3027

Cramp and spasm

227

1038

2.34

28.57

6.9

12.0

24.22

24.28

mmol/l

0.11

218

1019

Voice disturbances

1029

7161

1.47

28.57

9.8

9.4

24.43

24.29

mmol/l

0.74

1006

7031

Benign neoplasm: Transverse colon

523

3151

1.74

28.56

8.7

9.8

24.23

24.27

mmol/l

0.10

510

3094

Sulfonylureas

1492

8766

1.38

28.18

10.2

8.1

23.81

24.39

mmol/l

6.73

1428

8511

Other necrotizing vasculopathies (FG)

282

1409

2.13

28.15

10.2

24.44

24.23

mmol/l

0.55

273

1373

malignant neoplasm of male genital organs

1237

5303

1.44

28.07

8.3

11.5

23.84

24.18

mmol/l

3.19

1213

5149

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1216

8601

1.42

28.05

10.7

11.1

24.29

24.16

mmol/l

0.75

1190

8454

Other diseases of oesophagus

430

2460

1.83

28.04

9.9

9.3

24.68

24.26

mmol/l

1.44

420

2402

Disorders of psychological development

359

1782

1.92

28.02

14.9

12.3

24.24

24.02

mmol/l

0.66

350

1746

Other necrotizing vasculopathies

340

1817

1.98

27.97

10.5

9.4

24.33

24.27

mmol/l

0.13

329

1780

Molar incisor enamel hypoplasia, with caries

114

5.83

27.91

37.6

16.7

23.03

23.62

mmol/l

0.75

114

Type 1 diabetes, strict (exclude DM2)

295

1486

2.05

27.78

15.6

11.1

22.70

24.31

mmol/l

8.45

283

1470

Zoster [herpes zoster]

784

5210

1.55

27.71

9.7

9.0

24.35

24.33

mmol/l

0.07

761

5092

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

342

1836

1.96

27.58

15.8

8.7

24.08

24.29

mmol/l

0.63

335

1799

Injuries to the neck

840

5653

1.52

27.58

11.7

10.3

24.50

24.21

mmol/l

1.73

819

5545

Thyrotoxicosis

924

6344

1.49

27.49

11.4

9.2

24.59

24.33

mmol/l

1.75

908

6223

Fracture of neck

308

1608

2.04

27.29

14.8

9.4

24.70

24.17

mmol/l

1.68

301

1570

Postprocedural musculoskeletal disorders, not elsewhere classified

345

1870

1.96

27.23

8.6

9.5

24.34

24.26

mmol/l

0.19

340

1837

Allergic conjunctivitis

1884

13932

1.32

27.22

9.4

10.0

24.40

24.31

mmol/l

0.58

1832

13668

Osteoporosis with pathological fracture (FG)

320

1691

1.99

27.05

9.7

7.5

25.17

24.60

mmol/l

1.65

312

1643

Other disorders of lacrimal gland

1383

10208

1.38

27.04

8.9

9.5

24.58

24.33

mmol/l

2.35

1345

10015

Other problems related to primary support group, including family circumstances

346

1809

1.92

26.99

17.2

11.5

24.02

24.14

mmol/l

0.29

341

1785

Primary_lymphoid and hematopoietic malignant neoplasms

1035

7310

1.46

26.79

10.9

9.3

24.17

24.26

mmol/l

0.43

1011

7131

Appendectomy

2280

17143

1.28

26.59

10.9

10.2

24.20

24.28

mmol/l

0.55

2231

16800

Eating disorders

299

1538

2.00

26.56

10.0

10.8

24.41

24.04

mmol/l

1.08

286

1508

Migraine without aura

522

3167

1.68

26.55

10.3

10.1

24.24

24.09

mmol/l

0.55

513

3112

Conjunctivitis (acute, non atopic), including avohilmo

3941

19794

1.21

26.50

9.5

10.3

24.40

24.22

mmol/l

3.04

3844

19376

Fracture at wrist and hand level

1297

9482

1.39

26.32

10.7

24.26

24.20

mmol/l

0.26

1274

9295

Familial hypercholesterolemia, with ischemic heart disease

425

2476

1.80

26.23

10.6

8.3

24.01

24.35

mmol/l

1.27

413

2418

Localized swelling, mass and lump of skin and subcutaneous tissue

1245

9087

1.40

26.22

9.3

9.9

24.28

24.26

mmol/l

0.09

1215

8908

Heartburn

441

2582

1.77

26.22

12.0

9.6

24.53

24.23

mmol/l

1.31

436

2537

Malignant melanoma, including Hilmo

667

4331

1.59

26.17

8.4

9.4

24.29

24.36

mmol/l

0.25

655

4202

Cervicalgia

787

5294

1.52

25.99

8.0

9.8

24.47

24.23

mmol/l

1.29

774

5190

Other diseases of upper respiratory tract

4335

18946

1.20

25.93

10.1

10.0

24.36

24.20

mmol/l

2.61

4238

18484

Thyrotoxicosis, other and/or unspecified

734

4870

1.55

25.92

12.4

9.3

24.56

24.33

mmol/l

1.18

720

4780

Other symptoms and signs involving general sensations and perceptions

203

926

2.34

25.74

7.4

10.1

24.88

24.28

mmol/l

1.62

197

904

Sleep disorders

3370

19111

1.23

25.68

9.4

10.3

24.35

24.27

mmol/l

0.71

3287

18718

Hemiplegia

234

1129

2.20

25.66

10.8

9.7

24.53

24.32

mmol/l

0.40

227

1102

Immunodeficiency with predominantly antibody defects

132

496

2.91

25.65

16.9

11.3

24.35

24.28

mmol/l

0.08

127

490

Dronedarone medication

147

586

2.74

25.46

10.0

7.7

24.77

24.34

mmol/l

0.83

142

580

Pulmonary oedema

116

412

3.15

25.34

12.3

8.5

24.17

24.51

mmol/l

0.38

110

401

!Aliquae complicationes praecoces traumatis

217

1024

2.26

25.34

9.9

11.7

24.28

24.32

mmol/l

0.05

212

1003

Early complications of trauma

217

1024

2.26

25.34

9.9

11.7

24.28

24.32

mmol/l

0.05

212

1003

Irritable bowel syndrome

885

6113

1.48

25.29

8.7

9.3

24.28

24.33

mmol/l

0.18

860

5991

Acetic acid derivatives and related substances

1102

4017

1.44

25.24

8.3

11.1

24.09

24.07

mmol/l

0.05

1074

3895

Other blood glucose lowering drugs, excl. Insulins

667

4376

1.58

25.20

11.4

8.7

24.20

24.43

mmol/l

0.97

646

4267

Thiazolidinediones

499

3068

1.70

25.10

13.2

9.3

24.11

24.40

mmol/l

1.05

486

3004

Somatoform disorder

553

3470

1.64

24.99

8.0

10.1

24.63

24.22

mmol/l

2.33

538

3413

Disorders of conjunctiva

3052

19366

1.23

24.97

9.8

10.2

24.41

24.26

mmol/l

1.83

2982

18955

Chronic sinusitis

1558

11820

1.34

24.96

9.4

9.9

24.36

24.22

mmol/l

1.03

1519

11584

Other disorders of eyelid

1847

13553

1.31

24.88

8.2

9.0

24.56

24.28

mmol/l

3.72

1791

13223

Other degenerative diseases of the nervous system

1059

5487

1.43

24.85

7.7

8.9

24.30

24.15

mmol/l

0.69

1022

5350

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

536

3318

1.66

24.81

8.6

7.6

24.00

24.30

mmol/l

1.32

522

3189

Spondylolisthesis/Spondylolysis

703

4671

1.55

24.79

7.6

9.9

24.32

24.26

mmol/l

0.21

694

4594

Malignant neoplasm of other and unspecified parts of tongue

308

3.51

24.46

12.2

8.1

25.05

24.60

mmol/l

0.96

303

Polyarthrosis

808

4972

1.50

24.39

6.2

9.7

24.72

24.46

mmol/l

1.54

788

4853

Malignant neoplasm of prostate, including Hilmo

1217

5224

1.41

24.36

8.2

11.3

23.81

24.17

mmol/l

3.44

1194

5073

Squamous cell neoplasms and carcinomas of the skin

442

2650

1.74

24.29

8.3

7.4

23.84

24.29

mmol/l

2.21

429

2543

Childhood asthma (age<16), excluding more controls

273

1077

2.01

24.29

12.1

9.2

23.91

23.55

mmol/l

1.10

268

1057

Speech disturbances, not elsewhere classified

409

2409

1.78

24.22

10.1

9.4

24.72

24.21

mmol/l

2.88

404

2353

Other disorders of nervous system

308

1672

1.95

24.16

7.9

10.8

24.58

24.35

mmol/l

0.65

301

1646

Other renal tubulo-interstitial diseases

108

375

3.11

24.13

13.4

8.0

24.10

24.58

mmol/l

0.80

101

366

Injuries to the wrist and hand

3875

21555

1.20

24.10

11.0

10.0

24.27

24.24

mmol/l

0.26

3798

21063

Lack of expected normal physiological development

168

4.02

24.02

24.9

16.6

23.93

23.65

mmol/l

0.29

168

Hypertrophic cardiomyopathy

216

1047

2.22

23.79

19.5

10.2

23.91

24.20

mmol/l

0.58

211

1035

Malignant melanoma of skin

467

2857

1.69

23.70

7.9

9.7

24.28

24.33

mmol/l

0.16

458

2785

Malignant neoplasm of breast, ER-negative, including Hilmo

656

4042

1.55

23.64

7.9

8.0

24.54

24.61

mmol/l

0.22

642

3922

Embolic stroke

231

1147

2.14

23.53

11.9

7.9

24.61

24.28

mmol/l

0.75

221

1108

Speech and linguistic disorders

284

1438

1.96

23.44

15.8

13.1

24.11

24.05

mmol/l

0.13

278

1408

Visual field defects

371

2147

1.81

23.42

10.6

9.7

23.89

24.27

mmol/l

1.41

365

2106

Other symptoms and signs involving the circulatory and respiratory systems

252

1286

2.04

23.40

9.2

9.9

24.63

24.02

mmol/l

2.10

247

1265

Insomnia

3260

18795

1.22

23.37

9.4

10.3

24.33

24.28

mmol/l

0.45

3182

18405

Radiculopathy

642

4242

1.56

23.33

7.1

9.3

24.44

24.27

mmol/l

0.80

620

4142

Meniscus derangement

2126

11175

1.28

23.30

8.4

10.8

24.26

24.33

mmol/l

0.46

2088

10920

Diffuse brain injury

153

643

2.52

23.26

12.6

11.0

24.28

24.20

mmol/l

0.09

146

629

Disorders of lacrimal system

1633

12415

1.31

23.08

8.5

9.4

24.54

24.31

mmol/l

2.28

1589

12160

Malignant melanoma of skin, including Hilmo

543

3467

1.62

23.04

8.1

9.7

24.27

24.31

mmol/l

0.14

533

3372

Symptoms and signs involving emotional state

133

527

2.70

23.03

9.7

11.0

24.16

24.28

mmol/l

0.16

128

518

Malignant neoplasm of liver and intrahepatic bile ducts

165

726

2.46

23.03

14.8

9.2

23.62

24.15

mmol/l

1.25

160

705

Degeneration of macula and posterior pole

2096

12872

1.28

22.91

8.0

8.7

24.21

24.33

mmol/l

1.01

2025

12528

Bulimia nervosa (incl. atypical)

104

361

3.02

22.89

9.9

8.6

24.32

23.93

mmol/l

0.49

351

Immunodeficiencies

206

991

2.21

22.85

15.2

11.4

24.56

24.34

mmol/l

0.44

197

975

Oter anti-inflammatory and antirheumatic agents, non-steroids

936

3611

1.46

22.52

9.1

10.9

24.41

24.11

mmol/l

1.93

903

3499

Disorders of skin appendages

1703

13200

1.30

22.50

10.3

10.1

24.19

24.23

mmol/l

0.23

1665

12950

Other inflammation of eyelid, including avohilmo

1499

11488

1.32

22.49

9.2

10.4

24.43

24.22

mmol/l

2.05

1465

11277

Childhood asthma (age<16)

273

1108

1.96

22.45

12.1

10.1

23.91

23.59

mmol/l

0.93

268

1088

Disorders of the thyroid gland

3575

19439

1.20

22.44

10.1

9.7

24.29

24.22

mmol/l

0.71

3498

18969

Carbimazole or st.post thyroidectomy, condition for graves disease

718

4889

1.50

22.40

12.0

9.6

24.51

24.32

mmol/l

0.84

703

4810

Orchitis and epididymitis

425

2582

1.72

22.39

11.8

11.2

24.04

24.16

mmol/l

0.31

406

2526

Malignant neoplasm of prostate

1184

5150

1.39

22.31

8.1

11.3

23.81

24.16

mmol/l

3.31

1160

5002

Inguinal hernia

2363

12660

1.26

22.27

10.2

10.3

24.27

24.19

mmol/l

0.67

2303

12363

Caries of enamel

3576

19628

1.20

22.27

11.0

10.4

24.25

24.27

mmol/l

0.16

3518

19257

malignant neoplasm of female genital organs, including Hilmo

551

3378

1.59

22.26

7.9

7.8

24.44

24.66

mmol/l

0.81

535

3276

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

336

3.23

22.21

10.1

9.5

24.33

24.64

mmol/l

0.43

330

Other inflammatory liver diseases

280

1514

1.94

22.18

12.5

10.6

24.01

24.35

mmol/l

0.79

273

1490

Use of pramipexole

877

6228

1.45

22.08

8.9

9.1

24.65

24.35

mmol/l

2.10

852

6103

Malignant neoplasm of renal pelvis, including Hilmo

245

3.69

21.95

12.6

8.3

23.13

24.29

mmol/l

2.30

239

Methotrexate

495

3126

1.63

21.95

11.7

9.3

24.54

24.16

mmol/l

1.67

482

3069

Malignant neoplasm of breast, HER-negative

607

3843

1.55

21.94

8.1

8.0

24.60

24.64

mmol/l

0.11

593

3725

Use of donepezil

442

6685

0.61

21.90

4.5

7.4

24.35

24.32

mmol/l

0.06

423

6437

Carcinoma in situ of skin of other and unspecified parts of face

417

2545

1.72

21.84

7.0

7.3

24.19

24.24

mmol/l

0.11

409

2469

Other disorders of bladder

505

3220

1.63

21.78

9.2

9.7

24.31

24.19

mmol/l

0.30

489

3144

Combinations of oral blood glucose lowering drugs

1156

8606

1.38

21.78

13.0

9.6

23.85

24.37

mmol/l

5.30

1136

8450

Coxarthrosis, primary

2531

17194

1.24

21.61

8.2

9.3

24.36

24.30

mmol/l

0.47

2469

16768

Hypocalcemia

126

511

2.70

21.22

10.5

10.3

23.47

24.51

mmol/l

2.02

120

506

Other and unspecified visual disturbances

419

2568

1.69

21.21

9.2

9.5

24.21

24.26

mmol/l

0.15

411

2526

Other condition

536

3478

1.59

21.20

9.0

10.4

24.35

24.27

mmol/l

0.22

530

3415

L01XE Protein kinase inhibitors

252

1346

2.00

21.09

9.0

9.7

24.38

24.27

mmol/l

0.20

245

1326

Unspecified misadventure during surgical and medical care

260

1400

1.96

21.03

14.1

10.4

24.21

24.27

mmol/l

0.10

252

1376

Acute and transient psychotic disorders

405

2463

1.70

20.99

9.9

10.8

25.01

24.29

mmol/l

4.25

395

2421

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] standard in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS